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Abstract
Background: The tetraspanins Tspan8 and CD151 promote metastasis, exosomes (Exo) being suggested to be
important in the crosstalk between tumor and host. The contribution of Tspan8 and CD151 to host versus tumor-
derived exosome (TEX) activities being not defined, we approached the questions using 3-methylcholanthrene-
induced (MCA) tumors from wt, Tspan8ko, CD151ko and Tspan8/CD151 (db)ko mice, implanted into tetraspanin-
competent and deficient hosts.
Methods: Tumor growth and dissemination, hematopoiesis and angiogenesis were surveyed in wild type (wt),
Tspan8ko, CD151ko and dbko mice bearing tetraspanin-competent and -deficient MCA tumors. In vitro studies
using tumor cells, bone marrow cells (BMC) and endothelial cells (EC) elaborated the mechanism of serum (s)Exo- and
TEX-induced target modulation.
Results: Tumors grew in autochthonous and syngeneic hosts differing in Tspan8- and/or CD151-competence.
However, Tspan8ko- and/or CD151ko-tumor cell dissemination and settlement in metastatic organs was significantly
reduced in the autochthonous host, and less severely in the wt-host. Impaired wt-MCA tumor dissemination in the
ko-host confirmed a contribution of host- and tumor-Tspan8/-CD151 to tumor cell dissemination, delivery of sExo and
TEX being severely impaired by a Tspan8ko/CD151ko. Coculturing tumor cells, BMC and EC with sExo and TEX revealed
minor defects in epithelial mesenchymal transition and apoptosis resistance of ko tumors. Strongly reduced migratory
and invasive capacity of Tspan8ko/CD151ko-MCA relies on distorted associations with integrins and CAM and missing
Tspan8/CD151-promoted recruitment of proteases. The defects, differing between Tspan8ko- and CD151ko-MCA,
were rescued by wt-TEX and, less efficiently Tspan8ko- and CD151ko-TEX. Minor defects in hematopoietic progenitor
maturation were based on the missing association of hematopoietic growth factors /− receptors with CD151 and,
less pronounced, Tspan8. Rescue of impaired angiogenesis in ko mice by wt-sExo and promotion of angiogenesis by
TEX depended on the association of Tspan8 and CD151 with GPCR and RTK in EC and tumor cells.
Conclusions: Tspan8-/CD151-TEX play central roles in tumor progression. Tspan8-/CD151-sExo and TEX contribute by
stimulating angiogenesis. Tspan8 and CD151 fulfill these tasks by associating with function-relevant proteins, the
additive impact of Tspan8 and CD151 relying on differences in preferred associations. The distinct Tspan8 and CD151
contributions suggest a blockade of TEX-Tspan8 and -CD151 promising for therapeutic intervention.
Keywords: Tspan8 knockout, CD151 knockout, Exosomes, Metastasis, Angiogenesis, Hematopoiesis
* Correspondence: claudia.pitzer@pharma.uni-heidelberg.de;
margot.zoeller@gmx.net
2Interdisciplinary Neurobehavioral Core, Institute of Pharmacology,
Ruprecht-Karls-University, Heidelberg, Germany
1Pancreas Section, University Hospital of Surgery, Ruprecht-Karls-University,
Heidelberg, Germany
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhao et al. Journal of Experimental & Clinical Cancer Research          (2018) 37:312 
https://doi.org/10.1186/s13046-018-0961-6
Background
Tumor progression depends on the crosstalk with the host
promoting angiogenesis, tumor cell migration and settle-
ment in distant organs [1]. Tumor cells support these
processes via provision of exosomes (Exo), which deliver
angiogenesis stimulating factors, chemokines, chemokine
receptors, adhesion molecules and proteases [2–5].
Exosomes, small vesicles delivered by many cells and
abundantly by tumor cells [6], are composed of a lipid
bilayer with incorporated and attached membrane mole-
cules. The small Exo cytoplasm contains cytosolic pro-
teins, coding and noncoding RNA and DNA [7]. Exo
distribute through the body, selectively bind to or fuse
with target cells or are uptaken [8, 9]. All Exo compo-
nents being function-competent [10, 11], binding/uptake
is accompanied by target modulation [3–5, 12]. Finally,
cells deliver several types of Exo [9] that differ by
early endosome (EE) origin from cytoplasmic organ-
elles or invaginated membrane domains, like caveolae,
clathrin-coated pits [11, 13] or tetraspanin-enriched
microdomains (TEM) characterized, besides others, by
distinct lipid composition [14, 15]. Notably, tetraspa-
nins are the only consistently enriched protein family
in Exo [9].
Tetraspanins are highly conserved 4-transmembrane
proteins with a small and a large extracellular loop [16].
The latter accounts for dimerization and association
with non-tetraspanin transmembrane partner molecules
[17]. Besides few direct protein-protein interactions, and
due to the lipid composition of TEM, tetraspanins are
characterized by a multitude of attached proteins, in-
cluding integrins, CAMs, RTK, proteases, cytoskeleton
and cytosolic signal transduction molecules [18–20].
Tetraspanins mostly acting as molecular facilitators
via the associated proteins, it is important that tetra-
spanin webs are maintained during TEM invagination
and vesicle trafficking and are recovered in the released
Exo [21].
The tetraspanins CD151 and Tspan8 promote tumor
cell dissemination and metastasis [22, 23]. CD151 con-
tributes to pericellular MMP activation allowing for focal
ECM proteolysis [20] and influences MMP expression
and colocalization at the leading edge [24, 25]. CD151
also is engaged in focalizing laminin (LN)-binding α3β1
and α6β4, migration / invasion being strengthened by
α3β1 co-internalization [22, 26]. The association with
growth factor/chemokine receptors stimulates downstream
signaling activation [27] promoting carcinogenesis and
metastasis [28–30]. CD151 also supports angiogenesis. By
recruiting CD151, LN1-bound α6β1 stimulates embryonic
stem cell differentiation into endothelial cells (EC) [31].
HighTspan8 expression promotes hepatocellular carcinoma
lung metastases [32, 33] and ovarian cancer invasion [34].
Glioblastoma migration and drug resistance rely on Tspan8
complex formation and FAK activation [35]. Tspan8
complexes with α3 and rictor, a key component of the
mTORC2 complex, supports migration [36]. A contribu-
tion of Tspan8 to metastasis was confirmed by anti-Tspan8
inhibiting colon cancer growth in vivo, without affecting
proliferation and apoptosis resistance in vitro, which points
towards Tspan8 / Tspan8-complexes responding to envir-
onmental signals [37]. According to the TEM-derived
biogenesis, Exo-Tspan8 and -CD151 act in concert with
associated molecules. Thus, tumor Exo (TEX) Tspan8-α4β1
induce disseminated intravascular coagulation as a sequel of
overshooting angiogenesis [38]. On the other hand, Tspa-
n8-α6β4 TEX promote migration and metastasis [39],
also described for CD151-TEX [40].
Taken together, there is increasing evidence that the
engagement of CD151 and Tspan8 in tumor progression
and angiogenesis relies on the crosstalk between targets
and Tspan8+ / CD151+ Exo [21]. This assumption can
be controlled by implanting tetraspanin-competent and
-deficient tumors into wt hosts. Tumor implantation
into tetraspanin-ko hosts additionally allows to judge on
a host-derived Tspan8+ / CD151+ Exo contribution to
tumor progression. As previous work using Tspan8ko,
CD151ko and Tspan8ko/CD151ko (dbko) mice indicated
an additive engagement of CD151 and Tspan8 in
angiogenesis and keratinocyte migration, dbko MCA
tumors and dbko mice were included [41]. The analysis
of autochthonous and syngeneic tumors differing in
Tspan8 and/or CD151 competence confirmed the
importance of Tspan8 and CD151 in Exo biogenesis and
Exo target binding. Furthermore, Tspan8 and CD151
TEX show partially supplementing engagement in tumor
cell dissemination, distant organ settlement and
angiogenesis. Host tetraspanin-competent Exo contrib-
ute to tumor cell settlement in the bone marrow and
angiogenesis.
Methods
Mice and tumors
C57BL6 Tspan8ko, CD151ko and Tspan8ko/CD151ko
(dbko) mice and MCA-induced tumors in wt C57BL6
and the ko mice are described [41, 42]. Homozygosis
was controlled by genotyping (Primers: Additional file 1:
Table S1) [41, 42]. Tumors were maintained in
RPMI1640/10%FCS/antibiotics/glutamine and IGS sup-
plement (Sigma).
Antibodies and chemicals: Additional file 1: Table S2
Tissue collection
Solid organs and lymph nodes (LN) were shock frozen
or dispersed by meshing through fine gauze. Bone
marrow cells (BMC) were collected by flushing femora
and tibiae with PBS, peripheral blood leukocytes (PBL)
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was collected by heart puncture using heparinized
syringes, isolating PBL by Ficoll/Hypaque centrifugation.
Exosome preparation
sExo/TEX preparation and SP-Dio18(3)-labeling followed
described protocols [15], modified by 0.22 μm filtration
of cleared supernatants.
Sucrose density gradient centrifugation of cell lysates
Cell lysates in 2.5M sucrose were overlaid by a discon-
tinuous sucrose gradient (0.25M–2M) and centrifuged
(15 h, 150,000 g), collecting twelve 1ml fractions.
Immunoprecipitation (IP), Western blot (WB)
Cells were lysed in HEPES buffer/1%Lubrol/1 mM
PMSF/1mM NaVO4/10mM NaF/protease inhibitor mix
(30 min, 4 °C), mild lysis conditions were used for not
destroying loosely attached protein complexes. Lysates
were centrifuged (13,000 g, 10min, 4 °C), mixed with
antibody (1 h, 4 °C) and incubated with ProteinG-Sepharose
(1 h). Washed and dissolved complexes/lysates were
resolved on 10–12% SDS-PAGE, developing blots with
ECL after transfer, blocking and blotting.
Zymography
Culture supernatant of MCA tumors, starved for 24 h,
was centrifuged (15 min, 15,000 g). Aliquots, incubated
with Laemmli buffer (15 min, 37 °C), were separated in a
10% acrylamide gel containing 1 mg/ml gelatin. Washed
gels (2.5%Triton) were incubated in developing buffer
(37 °C, 48 h) and stained with Coomassie-blue.
Adhesion
Cells were seeded on BSA-, collagen (coll)-, laminin
(LN)-, or fibronectin (FN)-coated 24w-plates. After
adhesion (2 h, 37 °C, 5%CO2) and washing, adherent
cells were stained with crystal-violet, determining optical
density at 595 nm. Adhesion (triplicates) is presented as
% input cells.
Migration
Cells in the upper part of a Boyden chamber (RPMI/
0.1%BSA) were separated from the lower part (RPMI/
20%FCS) by 8 μm pore size polycarbonate-membranes.
After 16 h the lower membrane side was stained (crys-
tal-violet), measuring OD595 after lysis. Migration (trip-
licates) is presented as % input cells. In an in vitro
wound healing assay, a subconfluent monolayer was
scratched with a pipette tip. Wound closure was con-
trolled by light microscopy.
Invasion
Polycarbonate membranes (8 μm pore size) transwell
permeable supports were coated with 100 μl 1:5 diluted
Matrigel and kept in a humidified atmosphere (37 °C,
overnight). After washing, 5 × 104 cells in 200 μl RPMI/
1%BSA were placed on the gels. The lower chamber
contained RPMI/20%FCS. After 48 h (37 °C, 5%CO2),
cells not invading the gels were washed-off. Matrix
invasion and recovery on the lower membrane side
was evaluated microscopically and photometrically
after crystal-violet staining and lysis.
Soft agar assay
Tumor cells in 0.3% agar were seeded in 6-well plates on
a preformed 1% agar layer, counting colonies after 3wk.
Proliferation
Cells (2 × 104) were seeded in F-bottom 96-well plates
adding after 48 h 3H-thymidine (10 μCi/ml), evaluating
3H-thymidine incorporation after 16 h (β-counter).
Apoptosis
Cells (1 × 105) were grown for 48 h in RPMI/10%FCS con-
taining cisplatin. Survival was monitored by flow-cytometry
after annexinV-APC/PI staining or by the MTT assay or by
3H-thymidine uptake.
Flow-cytometry: TEX/sExo (10 μg) were coupled to
1 μl Latex beads (LB). After blocking (100 mM glycine)
and washing, TEX/sExo-loaded LB were stained using
the same standard protocol as for cells. For intracellular
staining, cells/LB-coated TEX/sExo were fixed and
permeabilized in advance. Samples were analyzed in a
FACSCalibur using the CellQuest program.
Histology
Snap frozen sections (8 μm) were fixed, incubated with
antibodies, washed, exposed to biotinylated secondary anti-
bodies and alkaline phosphatase conjugated avidin-biotin
solution. Sections were counter-stained with hematoxilin.
Digitized images were generated using a Leica DMRBE
microscope.
Confocal microscopy
Cells were fixed, permeabilized, blocked, incubated with
primary antibody, washed, incubated with Cy2-conjugated
secondary antibody and after washing and blocking
stained with an additional primary antibody and a
Cy3-conjugated secondary antibody. Slides were mounted
in Elvanol. Digitized images were generated using a Leica
LMS800 microscope and the Carl Zeiss Vision software
for evaluation.
In vivo assays
Mice received a subcutaneous (sc) application of 2 × 106
MCA tumor cells. Tumor growth was monitored weekly.
Mice were sacrificed when the local tumor reached a
mean diameter of 1.5 cm or latest after 240d. Mice were
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controlled for visible metastases. Blood, LN, bone
marrow, liver and lung were collected and cultured controlling
for latent tumor cell outgrowth. Animal experiments were
Government-approved (Baden-Wuerttemberg, Germany)
and carried out in accordance with EU Directive
2010/63/EU.
Statistics
P values < 0.05 (in vitro: two-tailed Student’s t-test, in
vivo: Kruskal-Wallis test after Bonferroni Holm correc-
tion, where indicated) were considered significant.
Results
Characterization of wt, Tspan8ko and/or CD151ko MCA-
tumors, endothelial cells, bone marrow cells, TEX and
serum exosomes
Exploring a possible impact of host Exo and TEX
Tspan8 and CD151 on tumor growth and progression
required a criss-cross evaluation of the MCA wt,
Tspan8ko and/or CD151ko tumors in the autochthonous
and the syngeneic host differing in Tspan8 and/or
CD151 competence. Awareness of cell and Exo/TEX
Tspan8- and CD151-dependent changes in the protein
profile being a prerequisite for the interpretation of in
vivo and functional in vitro studies, these data are sum-
marized for tumor cells / TEX, EC, BMC and sExo in
Additional file 1: Figure S1.
Tetraspanin expression of MCA tumors was evalu-
ated by flow-cytometry and WB. The tumors express
CD9 at a high, CD63 and CD81 at a rather low
level, mean level CD151 expression is abolished in
CD151ko- and dbko-MCA tumors and low level
Tspan8 expression in Tspan8ko- and dbko-MCA tumors
(Additional file 1: Figure S1a, c). Characterization of
the TEX protein profile became important as one
route of Exo biogenesis proceeds via TEM internaliza-
tion, trafficking of the originating EE involving tetra-
spanins [13, 43]. TEX express CD9, CD151 and
Tspan8 at a higher level than cells (Additional file 1:
Figure S1b, c).
MCA tumors express the tumor markers CD24,
S100A4, CD184, TGFβ1, CD138, thrombospondin
(ThbSp) and tissue factor (TF) at high to medium and
ALDH1/2, CD133, HSP70 and HSP90 at low level. Ex-
pression does not significantly differ between wt- and
ko-MCA lines (Additional file 1: Figure S1d). Expression
of the tumor markers HSP70 and HSP90 was signifi-
cantly higher in TEX than cells. Ko-TEX differed by
slightly reduced ThbSp recovery (Additional file 1:
Figure S1e). Similar findings accounting for several
ko-MCA-tumors (data not shown), we proceeded with
these lines.
The higher expression of tetraspanins and HSPs in
Exo being known [9], only ThbSp recruitment into ko
TEX was impaired.
Tetraspanins acting as molecular facilitators of associ-
ated molecules, the impact of Tspan8 and CD151 on
adhesion molecule, protease and signaling receptor
expression required exploration.
The MCA cells highly express CD44, CD29 and
CD49f. Expression of CD49f is slightly reduced in
ko-MCA cells, low CD49c and CD62L expression is
reduced in Tspan8ko−/dbko- and CD56 and CD106 in
CD151ko−/dbko-MCA (Additional file 1: Figure S1f, h),
reduced expression being also seen in ko-TEX. The most
impressive changes in TEX were increased recovery of
several integrins, CAMs and selectins. Reduced CD49c
in Tspan8ko- and CD56 and CD106 expression in
CD151ko-MCA cells and -TEX (Additional file 1:
Figure S1f-h) points towards a linkage of CD49c to
Tspan8 and of CD56 and CD106 to CD151.
Flow-cytometry and WB revealed high MMP2, MMP3,
uPA and ADAM10 and medium to low uPAR, MMP9,
MMP14 and TACE expression in wt-MCA cells. UPAR,
uPA, MMP2 and MMP3 expression was reduced in
Tspan8ko−/dbko-, TACE expression was reduced in
CD151ko/dbko, MMP9, MMP14 and ADAM10 expres-
sion was reduced in all 3 ko-MCA lines. Except for a
strong increase in uPAR, the protease expression profile
of MCA-TEX resembled that of cells (Additional file 1:
Figure S1i-k).
Tetraspanins cooperate with RTK [44]. High TGFβRI,
-II and VEGFR2 expression was reduced in the three ko
lines. PDGFRB, VEGFR3 and EphA4 expression was
only reduced in Tspan8ko MCA (Additional file 1:
Figure S1 l).
EMT and apoptosis-resistance are important tumor
parameters. Both epithelial E- and mesenchymal N-cadh
were expressed at a high level irrespective of a Tspan8ko
and/or a CD151ko. FN and vim expression are low, FN
expression being reduced in CD151ko-MCA cells. Only
the EMT-related transcription factors Nanog and slightly
NOTCH expression was reduced in the three ko lines
and FOXO3 and Frizzled expression in CD151ko cells
(Additional file 1: Figure S1 m). Low death receptor
expression was not affected by a Tspan8ko and/or a
CD151ko. BAD phosphorylation and BclXl expression
was slightly reduced in Tspan8ko cells, but proapop-
totic BAX expression was not affected. Unexpectedly,
Casp3 and cleaved Casp9 expression was slightly
reduced in Tspan8ko cells, but not TEX (Additional
file 1: Figure S1n, o).
Finally, a Tspan8ko did not affect the sExo profile and
in CD151ko- and dbko-mice only CD54 expression was
reduced. Thrombocyte markers (CD41, CD61) were
unaffected (Additional file 1: Figure S1p).
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BMC and EC were selected as non-transformed
cells. Tumor growth depends on angiogenesis [5],
which involves tetraspanins [45–49]. Tumor progres-
sion frequently is accompanied by anemia and devi-
ation of hematopoiesis towards immunosuppressive
components. The bone marrow also is a preferred
metastatic organ.
BMC were characterized by flow-cytometry for tetra-
spanin, progenitor marker, hematopoietic chemokine
and -receptor expression. There was a slight reduction
in CD9 expression in BMC of the 3 ko-mice, CD63
expression was reduced in CD151ko- and dbko-BMC.
KIT, CD34, CD62P, TER119 and Gr1 expression was
reduced in all 3 ko-BMC; CD44 expression was only
slightly reduced in CD151ko- and dbko-BMC. OPN
expression was reduced in the 3 ko lines, CXCL10 and
MCSFR expression was more strongly affected in
CD151ko−/dbko-BMC. In brief, Tspan8 and CD151
possibly affect early hematopoietic progenitors,
erythropoiesis and thrombopoiesis. (Additional file 1:
Figure S1q).
Tetraspanin expression was not affected in EC-enriched
cells, CD31 and CD34 EC marker expression was
slightly reduced in Tspan8ko−/dbko-EC, CD106 and
CD62P in CD151ko−/dbko-EC. OPN, VEGFR2 and
EphA4 were reduced in all 3 ko-EC and SDF1 in
CD151ko−/dbko-EC (Additional file 1: Figure S1r).
These findings would be in line with a minor impact
of Tspan8 and CD151 on EC progenitor maturation,
but impaired EC activation and proliferation.
Briefly, a Tspan8ko and/or a CD151ko only affect
expression of selected markers and the impact is
minor. In most instances the response to a Tspan8ko
and a CD151ko differed and was stronger in dbko
cells, which we interpret towards a partially additive
Tspan8 and CD151 contribution. Exosomes mostly
reflect the changes in the cellular protein profile.
However, in some instances differences between the
Tspan8ko and the CD151ko became hidden that may
relate to the pool of Exo deriving from distinct bio-
genesis pathways.
Tspan8- and CD151-dependent exosome delivery and
binding
Exo biogenesis can proceed via TEM internalization and
Exo use tetraspanin complexes for binding [15, 40].
Thus, Tspan8 and CD151 may affect sExo / TEX deliv-
ery and target binding.
First to note, ko-MCA secrete significantly less TEX
than wt-MCA (Additional file 1: Figure S2a) and fewer
sExo are recovered from ko- than wt-mice (Additional
file 1: Figure S2b). Wt-, Tspan8ko- and CD151ko-sExo
and -TEX uptake by Tspan8ko- and CD151ko-MCA is
not distorted. Instead, dbko-sExo and -TEX are poorly
taken-up by wt- and ko-MCA, examples being shown
for the uptake of TEX by CD9+ MCA cells (Additional
file 1: Figure S2c, d).
Reduced dbko-sExo and -TEX uptake also accounts
for EC, where Tspan8ko- and CD151ko-sExo uptake was
additionally impaired (Additional file 1: Figure S2e).
Instead, mostly CD151ko- and dbko-BMC displayed
reduced sExo/TEX uptake (Additional file 1: Figure S2f ).
Wondering whether this accounts for subpopulations,
unseparated BMC were incubated with Dio-labeled
wt-sExo and -TEX and stained for selected markers.
The analysis confirmed reduced recovery of KIT+ and
TER119+ and, less pronounced, Gr1+ Tspan8ko-,
CD151ko- and dbko-BMC, the percent of wt-sExo/−TEX
positive BMC being correspondingly decreased
(Additional file 1: Figure S2 g). Presenting the data as
relative percent of sExo+/TEX+ BMC revealed two infor-
mations. First, Gr1+ and CD11b + BMC take-up sExo/
TEX more avidly than KIT+ and TER119+ cells. Further-
more, KIT+ cells take-up TEX more readily than sExo
(Additional file 1: Figure S2 h).
The findings imply a strong impact of CD151 and
Tspan8 on sExo and TEX delivery. In addition, sExo/
TEX-Tspan8 and -CD151 contribute to target binding/
uptake. As only the uptake of dbko-sExo and -TEX was
consistently affected, we suggest that sExo/TEX-Tspan8
and -CD151 may mutually replace. The weaker effects of
dbko-sExo/TEX uptake by BMC and EC point towards
distinct tetraspanins, possibly CD9, CD63 or CD81,
being additionally engaged in uptake by BMC and EC.
Uptake of sExo may provide a continuous modulator
and uptake of TEX may account for reprogramming to-
wards facilitating angiogenesis, tumor cell dissemination
and settlement and/or for creating an immunosuppressive
milieu [50–53]. Tetraspanins being engaged in Exo bio-
genesis and targeting and coordinating associated mole-
cules’ activity, we expected unraveling a unifying concept
by evaluating the tetraspanin contribution, monitored for
Tspan8 and CD151 in MCA tumors, BMC and EC.
Tumor growth in wt- and ko-mice
Whether host Tspan8 and CD151 affect tumor growth,
was controlled by sc injection of wt- and
ko-MCA-tumors into wt- and ko-mice. The growth rate
differs for the 4 MCA lines. The dbko-MCA tumor
growing faster, tumor growth could only be compared
for the individual tumors in wt- versus ko-mice.
Wt-MCA-tumor growth was not affected in CD151ko-
compared to wt-mice, but was delayed in Tspan8ko-
and dbko-mice. Growth of slowly developing Tspan8ko-MCA
tumors was further delayed in dbko-mice. The growth
of CD151ko-MCA tumors was retarded in CD151ko-
and dbko-mice, the growth of dbko-MCA tumors was
delayed in all 3 ko-strains (Fig. 1a, b). The strongest
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retardation being seen in wt-MCA growth in
Tspan8ko and dbko mice was a first indication of
host sExo supporting tumor growth. This suggestion
was strengthened by evaluating tumor cell dissemin-
ation, which strongly differed between wt and ko
hosts, but also between wt and ko tumors. Tumor
cell outgrowth was evaluated in PB, LN, BM, lung
and liver after in vitro culture. Wt MCA cells were
regularly recovered in PB, LN, BM, lung and rarely
liver. Tumor cell dissemination was particularly af-
fected in Tspan8ko and dbko mice, also apparent by
the cumulated tumor cell dissemination. Similar find-
ings accounted for the three ko-MCA lines. Ko-MCA
tumors frequently developed LN and lung metastasis
in wt-mice, but only in 30–60% of the autochthonous
host, the lowest tumor load being observed in
dbko-mice. However, the dissemination capacity of
the ko MCA tumors was also significantly impaired,
when grown in wt-mice, which implies a contribution
of Tspan8- and CD151-TEX to dissemination, with a
stronger effect of Tspan8 than CD151. Finally, host
Tspan8- and CD151-Exo have a distinct impact on
dissemination in the blood versus settlement in dis-
tinct organs. Dissemination in the blood was most
strongly affected in CD151ko-mice, settlement in LN,
BM, lung and liver was more strongly impaired in
Tspan8ko−/dbko-mice (Fig. 1c).
Flow-cytometry of minced wt-MCA tissue at autopsy
showed reduced Tspan8 and VEGFR3 expression in
Tspan8ko- and dbko-mice, CD151 expression was re-
duced in CD151ko- and dbko-mice and VEGFR2 expres-
sion was affected in all 3 ko-strains. On the other hand,
Tspan8, VEGFR3, Lyve, MMP2 and TGFβ1 expression
of Tspan8ko-MCA became increased in wt-mice, but
Fig. 1 Tumor growth in Tspan8ko- and/or CD151ko-mice. Wt and ko
mice received a sc injection of 2 × 106 wt- or ko-MCA cells. a Initiation
of tumor growth and mean tumor diameter (6 mice/group); b survival
and mean survival time of wt- and ko-mice after sc injection of
wt- and ko-MCA tumor cells (5 mice/group); p-values are indicated;
c No of mice with migrating tumor cells (PB) and micrometastases in
draining LN, BM, lung and liver and mean frequency of mice with
disseminated tumor cells per tumor, per mice and per organ; p-values
(after Bonferroni Holm correction) are indicated; d Tabular overview of
shock frozen tumor sections (immunohistochemistry) of tetraspanins,
adhesion molecules, proteases and angiogenesis-related factors /
receptors in wt- and ko-MCA tumors grown in wt and ko mice.
Expression was judged as +++: very strong, ++: strong, +: distinct,
±: weak, ±: very weak; e immunohistochemistry examples of
tetraspanin expression in wt and ko MCA grown in wt and ko mice
(scale bar: 100 μm). Tumor growth initiation of wt- and ko-MCA tumors
is retarded in ko mice and tumor growth progresses very slowly.
Tumor cell dissemination is severely impaired in ko mice, but ko MCA
dissemination is promoted in wt mice accompanied by upregulation
of adhesion molecules, proteases and angiogenesis markers. Dbko-MCA
cells grown in dbko mice were very necrotic. The findings indicate
compensatory activities of the host
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CD106 and VEGFR2 expression was further reduced in
CD151ko−/dbko-mice. Finally, CD151 and VEGFR2
expression of CD151ko-MCA was strengthened in wt-
and Tspan8ko-mice and VEGFR3 expression in wt-mice
(Additional file 1: Figure S3a). The finding suggests that
VEGFR3 and MMP2 deficits in Tspan8ko mice and
VEGFR2, CD56 and CD106 deficits in CD151ko mice
may be partly rescued by wt-sExo.
Immunohistochemistry of shock frozen tumor sections
supported the flow-cytometry analysis, where weak ex-
pression in the tumor tissue should be taken into ac-
count to avoid overestimation of changed expression
(Fig. 1d). Slightly reduced CD9 expression in Tspan8ko-
and dbko-MCA is increased in wt-mice. Tspan8 expres-
sion in wt-MCA becomes reduced in Tspan8ko- and
dbko-mice, but Tspan8ko- and dbko-MCA display in-
creased expression in wt-mice. Similar host-dependent
changes are seen in CD151 expression (Fig. 1d, e).
Due to the link of tetraspanins with adhesion mole-
cules and proteases [41, 42] their regulation in wt- and
ko-hosts became of special interest. CD49c, CD104,
CD56 and CD106 expression in wt-MCA was slightly re-
duced in CD151ko- and dbko-hosts. Lower expression
in ko-, particularly CD151ko-MCA was mostly upregu-
lated in the wt-host (Fig. 1d). Wt-MCA MMP9 expres-
sion was slightly reduced in ko-mice, but MMP2 and
MMP9 expression of Tspan8ko- and dbko-MCA was
increased in wt- and CD151ko-mice. MMP2, MMP9
and uPAR expression of dbko-MCA was increased in
wt- and single ko-mice (Fig. 1d, Additional file 1:
Figure S3b).
VEGFR2, VEGFR3 and Lyve expression in wt-MCA
tumors is slightly reduced in ko-mice, but expression of
VEGFR3 and Lyve in ko-MCA becomes stronger in
wt-mice. CD31+ cells in wt-MCA tumors were reduced
in ko-, most strongly CD151ko-mice, but were increased
in CD151ko- and dbko-MCA tumors grown in wt-mice
(Fig. 1d, Additional file 1: Figure S3c).
Reduced SDF1+ and TF+ cell recovery in wt-MCA
tumors grown in ko-mice and rescue of these markers in
Tspan8ko- and dbko-MCA tumors, when grown in
wt-mice, were most prominent changes in tumor
markers (Fig. 1d).
Taken together, host and tumor Tspan8 and CD151
contribute to tumor progression, with only a partial
overlap of Tspan8- and CD151-deficits, apparent by the
stronger defects of dbko-MCA in dissemination, more
strongly impaired angiogenesis of CD151ko MCA and
more pronounced deficits in Tspan8ko MCA in distant
organ settlement. Flow-cytometry and immunohistology
provided first hints towards distinct adhesion molecules,
proteases, GPCR and RTK accounting for impaired ko
tumor cell dissemination. Furthermore, tumor growth in
wt versus ko mice confirmed that wt-sExo can partially
cope with ko-MCA deficits. To control these assump-
tions and to unravel the Tspan8 and CD151 engagement,
MCA cells, EC and BMC were cocultured with wt-sExo
or wt- and ko-TEX searching for changed functions and
hints towards the underlying mechanism.
Tspan8- and CD151-TEX do not promote apoptosis
resistance or a shift towards EMT in MCA tumors
TEX promote high apoptosis resistance of tumor cells
[54–56]. The MCA tumors display low apoptosis resist-
ance and the rate of AnnV/PI stained cells did not
significantly differ between wt- and ko-MCA tumors
after 48 h culture in the presence of cisplatin, confirmed
in an MTTassay. However, proliferative activity particularly
of dbko-MCA tumors declined more rapidly (Additional
file 1: Figure S4a). Addition of wt-TEX, but not ko-TEX
promoted proliferative activity of cisplatin-treated
(2.5 μCi/ml) Tspan8ko- and CD151ko-, but not
dbko-MCA cells (Additional file 1: Figure S4b). Flow
cytometry revealed that impaired PI3K/Akt activation
of the ko MCA cells became mitigated in the pres-
ence of wt-TEX. Concomitantly pBAD and BclXl
expression became upregulated (data not shown). The
finding argues for an engagement of Tspan8 and
CD151 in PI3K/Akt pathway activation. As Tspan8ko and
CD151ko MCA equally well responded to wt-TEX treat-
ment, the failure of dbko MCA may rely on poor TEX
uptake. Nonetheless, the weak impact exclusively on pro-
liferative activity argues against a Tspan8ko/CD151ko
affecting MCA apoptosis resistance.
Tumor cells are characterized by anchorage independ-
ent growth and the capacity for EMT, which can initiate
or support tumor cell dissemination. Soft agar colony
formation of wt MCA was reduced in Tspan8ko- and/or
CD151ko-MCA and was partially rescued by wt-TEX
(Fig. 3a). Seeding Tspan8ko- and CD151ko-MCA at a
low density in medium supplemented with 20 μg/ml
wt-TEX, promoted proliferation accompanied by a
minor shift towards a more fibroblastoid shape, which
was not seen culturing MCA with ko-TEX (Fig. 3b, Add-
itional file 1: Figure S5a, b). The tumor markers
ALDH1/2, CD133 and CD24 expression was slightly in-
creased (Additional file 1: Figure S5c). However, reduced
FN, FOXO3 and Frizzled expression in CD151ko- and
dbko-MCA cells was not or hardly rescued by wt-TEX.
Only NOTCH and Nanog expression became restored
inTspan8ko- and CD151ko-MCA (Fig. 2c, d). Nanog,
NOTCH and Snail also were recovered in the nucleus of
wt- and Tspan8ko-MCA and nuclear recovery of Nanog
and NOTCH was stronger after wt-TEX treatment of
Tspan8ko-MCA (Fig. 2e). But, NOTCH and Nanog also
became upregulated by coculture with ko-TEX (Fig. 2f ).
Thus, TEX slightly promote proliferation and a
Zhao et al. Journal of Experimental & Clinical Cancer Research          (2018) 37:312 Page 7 of 23
partial shift towards EMT, which is Tspan8- and
CD151-independent.
The minor impact of a Tspan8ko and/or CD151ko on
MCA tumorigenic features is in line with unimpaired
MCA tumor-induction in the ko-mice. Though with the
exception of Nanog and NOTCH, these minor alter-
ations were connected to Tspan8 and CD151, the weak
effects unlikely account for the strong impact of a
Tspan8ko and a CD151ko on MCA dissemination.
Tspan8 and CD151, tumor cell adhesion / migration and
the impact of TEX
Tspan8 and CD151 preferentially associate with
LN-binding integrins, which affects adhesion and motil-
ity. Compared to wt-MCA, adhesion of ko-MCA cells to
BSA-coated plates was slightly reduced. However,
wt-MCA cells poorly adhered to matrix proteins, adhe-
sion of Tspan8ko- and CD151ko-MCA cells being even
weaker and dbko-MCA cells did not adhere (Fig. 3a).
Distinct to matrix proteins, wt-sExo and -TEX promoted
adhesion. Adhesion-supporting activity of Tspan8ko-
and CD151ko-TEX was faint and dbko-TEX were ineffi-
cient (Fig. 3b).
Transwell migration and migratory activity in the
scratch assay (in vitro wound healing) of ko-MCA cells
is impaired (Fig. 3c). This accounted for migration on
BSA- and matrix protein-coated plates. Migration of
wt-MCA was accelerated on coll I-, coll IV-, LN111- and
LN332-, but not FN-coated plates. Migration of
Tspan8ko- and particularly CD151ko-MCA was less
Fig. 2 Anchorage-independent growth, proliferative activity and EMT of wt- and ko-MCA tumor cells. a Examples of wt- and ko-MCA cell soft
agar colonies in the absence or presence of wt-TEX (30 μg/ml) and mean colony number/1000 cells±SD (3 assays); significant differences
between wt and kd cells and between controls and wt-TEX-treated cells are indicated; b wt- and CD151ko-MCA cells were seeded at low density
in 6-well plates in the absence or presence of wt-TEX. Cell density and morphological appearance were evaluated after 72 h by light microscopy
(scale bar: 100 μm); (c-f) wt- and ko-MCA tumor cells were cocultured with wt- and ko-TEX for 48 h. c Flow-cytometry analysis of EMT marker
expression and representative examples; d WB of EMT transcription factor expression; e WB of EMT transcription factor expression in the cytosol
and the nucleus; f Flow cytometry analysis of EMT transcription factor expression in Tspan8ko-MCA cells after coculture with wt- or ko-TEX; (c,f)
mean % stained cells±SD (3 assays); significant differences between wt- and ko-MCA: *, by coculture with TEX: s. Anchorage-independent growth
of ko-MCA cells is impaired and partly restored by wt-TEX. Wt-TEX promote a slight shift towards a more fibroid morphology. But, only reduced
Nanog and NOTCH expression become upregulated by wt- and ko-TEX without changes in nuclear recruitment. This argues against Nanog and
NOTCH upregulation being Tspan8- and CD151-TEX dependent
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efficiently supported. Dbko-MCA migration became
only accelerated on FN-coated plates (Fig. 3d). Only
wt-sExo/−TEX supported transwell migration and
wound healing, the poor response of dbko-MCA cells
indicating additive activities of Tspan8- and
CD151-competent TEX as well as additional defects
in dbko-MCA tumors (Fig. 3e, f ).
Reduced recovery of some adhesion molecules in
Tspan8ko- and CD151ko-cells and -TEX (Additional file 1:
Figure S1f-h) pointed towards an association with Tspan8
and CD151 and a joint transfer into TEX. Confocal micros-
copy indicated pronounced CD49f-Tspan8 and CD49f-CD9
colocalization in CD151ko-MCA. But, CD106 did not
colocalize with CD9 or Tspan8 in CD151ko-MCA. F-actin
Fig. 3 Adhesion and migration of wt- and ko-MCA tumor cells. a Tumor cells were seeded on matrix protein-coated plates. After 4 h incubation
and washing, the percent of adherent cells was evaluated by crystal-violet staining measuring OD585; b MCA cells were seeded on BSA-coated
plates, the medium containing 10% Exo-depleted FCS or 30 μg/ml wt-sExo or -TEX. After 4 h incubation and washing, the percent of adherent
cells was evaluated by crystal-violet staining measuring OD585; a, b mean values±SD (triplicates), significant differences between wt- and ko-cells:
*; significant differences between BSA- versus matrix protein-coated plates and between Exo-depleted FCS and sExo or TEX: s; c transwell
migration of wt- and ko-MCA cells towards BSA versus 20% FCS; mean % migrating cells±SD (triplicates); significant differences in transwell
migration between wt- and ko-MCA tumor cells: *; d in vitro wound healing of wt- and ko-MCA cells was evaluated by the scratch assay. After
reaching subconfluence, the monolayer was scratched and wound healing was followed microscopically for 48 h–72 h. Representative examples
of wt- and ko-MCA cells seeded on coll I-coated plates (wound edge are indicated by a dashed line) and on BSA-, coll I-, coll IV-, LN111-, LN332-
or FN-coated plates; the mean % wound area ± SD (3 assays) are shown; the mean % differences in the wound area compared to BSA-coated
plates are listed in the table, significant differences are shadowed; e transwell migration of wt- and ko-MCA cells towards BSA versus wt-sExo and
wt- and ko-TEX was evaluated in Boyden chambers after 16 h of incubation; mean % migrating cells±SD (triplicates); significant differences in
migration towards BSA versus sExo and TEX: s; f wound healing of ko-MCA cells seeded on BSA-coated plates was evaluated in the presence of
medium containing 10% Exo-depleted FCS or wt- and ko-TEX (30 μg/ml) after 24 h; the mean % wound area ± SD (triplicates), significant
differences between Exo-depleted FCS versus TEX containing medium: s. Transwell migration and in vitro wound healing of ko-, most strongly
dbko-MCA cells is impaired, the difference in wound healing being maintained in matrix protein-coated plates, where distinct to Tspan8ko- and
CD151ko-MCA cells, dbko-MCA only migrate on FN-coated plates. Migration is promoted by wt-TEX and, weakly, by Tspan8ko- or CD151ko-TEX in
CD151ko-, respectively, Tspan8ko-MCA cells
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Fig. 4 (See legend on next page.)
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preferentially colocalized with Tspan8. In dbko-MCA,
colocalization with CD9 was reduced (Fig. 4a).
Co-immunoprecipitation confirmed an association of
CD49f and CD49c with Tspan8 and CD151 and of CD56
and CD106 with CD151 in cells and TEX. However, after
cells were cocultured with wt-TEX, particularly CD151 was
recovered in the IP of CD151ko-MCA such that the co-
immunoprecipitation pattern lost in selectivity (Fig. 4b).
TEM recovery in light density sucrose gradient frac-
tions provides an additional option to control for
CD151/Tspan8-adhesion molecule associations. CD49f
and CD49c were partially shifted towards heavier
fractions in Tspan8ko-, CD151ko- and, more strongly,
dbko-MCA cells. Instead, CD56 and CD106 were relo-
cated into heavy fractions only in CD151ko and dbko
cells. Both, a Tspan8ko and a CD151ko also, albeit
slightly, affected CD9 recovery in light density fractions
and, unexpectedly, Tspan8 contributed to CD151 recov-
ery in light density fractions and vice versa (Fig. 4c).
Thus, CD151- and Tspan8-associated adhesion mole-
cules in TEX contribute to migration. In the MCA tu-
mors this relies predominantly on CD49c-, CD49f- and
(not shown) CD104-associated Tspan8 and on CD56-
and CD106-associated CD151.
Tspan8 and CD151, invasion and the contribution of TEX
proteases
Tetraspanin-associated proteases in cells and TEX contrib-
ute to matrix degradation and tissue invasion [57–60].
Wt-TEX strongly degrade collagen IV and LN332 and
significantly coll I. FN is not degraded. Whereas degrad-
ation of coll I, coll IV and LN332 is partly maintained in
single Tspan8ko- and CD151ko-TEX, no degradation is
seen with dbko-TEX (Fig. 5a). Zymography confirmed low
MMP9 and high MMP2 expression in MCA tumor super-
natant, MMP9 recovery being nearly abolished and MMP2
expression strongly reduced in Tspan8ko- and dbko-MCA
supernatants (Fig. 5b). Matrigel invasion and penetration of
the ko-MCA cells is significantly impaired, with a stronger
impact of Tspan8 than CD151 and a more pronounced
reduction of dbko-MCA cells (Fig. 5c). Reduced invasive-
ness of Tspan8ko- and CD151ko-MCA cells is restored by
wt- and to some degree by Tspan8ko- and CD151ko-, but
not dbko-TEX (Additional file 1: Figure S6a, Fig. 5d).
TEX did not affect protease expression in wt-MCA.
Instead, protease expression was rescued by wt- and
CD151ko-TEX in Tspan8ko-MCA. Wt-TEX also sup-
ported MMP2, MMP3, MMP7, MMP14 and TACE
expression in CD151ko-MCA. A weak effect of
Tspan8ko-TEX was only seen in membrane-anchored
MMP14 and TACE. Dbko-MCA protease expression was
upregulated after coculture with wt-TEX. Tspan8ko-TEX
only promoted MMP14 expression (Additional file 1:
Figure S6b). The strong impact of wt-TEX on dbko-MCA
cells may rely on recruitment via MMP14, not being
essentially linked to TEM-derived TEX. To control the
hypothesis, colocalization of proteases with tetraspanins
was evaluated.
Unexpectedly, CD9 colocalizes with MMP2 and TACE
in dbko-MCA, but poorly in Tspan8ko- and
CD151ko-MCA cells, indicating CD9 taking over
compensatory activity in the absence of both Tspan8 and
CD151 (Fig. 6a). In wt- and CD151ko-MCA cells
MMP2, MMP9, TACE and weakly MMP14 colocalize
with Tspan8. CD151 colocalizes with TACE in wt- and
Tspan8ko-MCA cells (Fig. 6b). Coimmunoprecipitation
of proteases with CD9, Tspan8 and CD151 after mild
lysis avoiding TEM complexes disruption confirmed
CD9 coimmunoprecipitation with MMP2, MMP9, uPAR
and TACE in cells and TEX. Tspan8 and CD151 also
coimmunoprecipitated with these proteases, coimmuno-
precipitation of uPAR and TACE with Tspan8 and
CD151 being stronger in TEX than cells (Fig. 6c).
Sucrose gradient fractionation confirmed that in Tspan8ko-
and dbko-MCA lysates MMP2 was only recovered in
dense fractions and MMP9 was partly shifted to heav-
ier fractions. UPAR and TACE recovery in light frac-
tions was not affected in ko-lysates (Fig. 6d).
We interpret these findings that in MCA cells MMP2
and MMP9 preferentially associate with Tspan8. As
Tspan8 expression is weak, only a minor part of
proteases is tetraspanin-associated. uPAR and TACE
being not shifted to higher density fractions in ko-MCA
cells indicates colocalization being (Tspan8- and
CD151-)TEM-independent. Nonetheless, by the recruitment
(See figure on previous page.)
Fig. 4 Adhesion molecule location and association with tetraspanins in wt- and ko-MCA tumor cells. a Colocalization of CD49f, CD106 and F-
actin (Phalloidin) with CD9, Tspan8 and CD151 was evaluated by confocal microscopy. Representative examples of single staining and overlays
are shown (scale bar: 10 μm); b coIP of CD49f, CD49c, CD56 and CD106 with CD9, CD151 and Tspan8 in wt- and ko-MCA cells, TEX and wt-TEX-
treated cells; c WB of wt- and ko-MCA cell lysates after sucrose gradient centrifugation, where the light fractions (1–4) were tested individually
and medium dense fractions 5–8 and dense fractions 9–12 were pooled; representative examples are shown and the mean intensity of light
fractions (1–4) in comparison to all fractions (3 assays) is shown; significant differences in the recovery in light fractions between wt- and ko-MCA
cells: *. CD49f most prominently colocalizes with CD9 and Tspan8 in CD151ko-MCA, whereas CD106 preferentially colocalizes with CD151. F-actin
associates with CD9 and Tspan8, but hardly with CD151. CoIP confirmed preferential association of CD49f and CD49c with Tspan8 and of CD56
and CD106 with CD151 in cells and, less pronounced, TEX and wt-TEX-treated cells. In MCA cells, the association of adhesion molecules with
tetraspanins is accompanied by pronounced recovery in light density (TEM) fractions
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of proteases into TEX, wt-TEX strongly promote
MCA cell invasion.
In brief, in vitro studies revealed a minor decrease in
apoptosis resistance of Tspan8ko- and/or CD151ko-MCA
cells due to impaired PI3K/Akt pathway activation. The
defect was covered by wt-TEX. Wt-TEX also partially
coped with impaired anchorage-independent growth of
the ko-MCA lines. There was no evidence for a selective
contribution of Tspan8 and CD151 to EMT. Thus, CD151
and Tspan8 are not involved in oncogenesis/oncogenicity
of MCA tumors. Instead, a Tspan8ko and a CD151ko
affect tumor cell dissemination, which relies on poor
recruitment of integrins, CAMs and proteases into TEM /
TEM-derived TEX. Tspan8- and CD151-associated mole-
cules are only partly overlapping, accounting for stronger
deficits in dbko-MCA. Fittingly, wt- and to a minor degree
Tspan8ko- and CD151ko-, but not dbko-TEX suffice for
correction. Colocalization and coimmunoprecipitation
with CD9 in the absence of Tspan8 or CD151 point
towards an engagement of additional tetraspanins,
particularly in protease recruitment.
We have not yet taken into account retarded growth
start and impaired settlement of wt-MCA in ko-mice.
Both features suggest a Tspan8- or CD151-dependent
impact of TEX on host cells [61] and a Tspan8- or
CD151-dependent contribution of host Exo, which was
controlled for BMC and EC.
Serum exosomes and TEX and hematopoiesis / the
premetastatic niche
Ko-MCA settlement in the BM was most strongly
impaired in the ko host (Fig. 2c) and TEX can account
for tumor progression-associated anemia and immune
deviation [62]. A potential impact of Tspan8 and CD151
Fig. 5 Invasion of wt- and ko-MCA tumor cells. a Wt- and ko-TEX (20 μg/ml) were cocultured with 1 μg matrix proteins for 48 h; matrix protein
degradation was evaluated by WB, representative examples are shown; b zymography of wt- and ko-MCA culture supernatant collected after 48 h
culture in the absence of FCS; MMP9 and MMP2 are indicated; c wt- and ko-MCA cells were seeded on matrigel; invasion (crystal-violet staining
of matrigel embedded cells) and penetration (counting cells at the lower membrane site after crystal-violet staining) was evaluated after 48 h
incubation; representative examples and mean % invading±SD / No of penetrating cells±SD (triplicates) are shown; significant differences in
invasion and penetration between wt- and ko-MCA tumor cells: *; d ko-MCA cells were seeded on matrigel containing 50 μg/ml TEX. Evaluation
was performed as described in (c); mean % invading±SD / No of penetrating cells±SD (triplicates) are shown; significant differences in invasion
and penetration in TEX-containing matrigel: s. Tspan8ko and dbko TEX poorly degraded coll I, coll IV and LN332 and gelatin. Invasion of
Tspan8ko- and/or CD151ko-MCA tumors is severely reduced, but partly rescued by wt-TEX and weakly by Tspan8ko- or CD151ko-TEX; dbko-TEX
are ineffective
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on hematopoiesis, immunosuppression and metastatic
niche preparation was evaluated by coculturing BMC
with sExo and TEX. Wt-sExo only corrected for reduced
CD44 and CD62P expression in ko-BMC. Instead, BMC
responded differently to wt-TEX versus ko-TEX. As far
as changes were observed in ALDH1/2 and the progeni-
tor markers CD44, CD62P, TER119, GR1 and CD11b, wt
and ko BMC responded alike to wt- and ko-TEX. In-
stead, KIT and CD34 only responded to wt-TEX and,
less pronounced to CD151ko-TEX. We did not see sig-
nificant differences in hematopoietic growth factors and
chemokines. The response to growth factor receptors
and chemokine receptors differed depending on TEX
and/or the BMC donor. Only wt-TEX suppressed
MCSFR expression in wt- and Tspan8ko-BMC. CCR5
expression was reduced in wt- and Tspan8ko-BMC by
wt- and Tspan8ko-TEX. CXCR3 expression solely was
upregulated by wt-TEX in wt-BMC. CD184 expression
became elevated in wt- and CD151ko-BMC by wt-TEX
and CD151ko-TEX and in Tspan8ko-BMC by wt-TEX.
FOXO3 expression was reduced in wt- and ko-BMC
treated with wt-TEX and in wt- and Tspan8ko-BMC cul-
tured with Tspan8ko-TEX (Fig. 7a-c, Additional file 1:
Figure S7a-c). We interpret these findings that the im-
pact of TEX on progenitor promotion or suppression is
Tspan8- and CD151-independent, whereas FOXO3 and
hematopoietic receptor modulation apparently relies on
cooperation with Tspan8 or CD151, which was con-
trolled by co-immunoprecipitation of FOXO3, KIT,
MCSFR, CD184, TER119 and CD11b with CD9, Tspan8
and CD151. TER119 and CD11b only coimmunoprecipi-
tated with CD9. Instead, KIT, MCSFR, CD184 and the
Fig. 6 Colocalization and coimmunoprecipitation of proteases with tetraspanins in wt- and ko-MCA cells. Confocal microscopy of MMP2, MMP9,
MMP14 and TACE with (a) CD9 and (b) Tspan8 and CD151 in wt- and ko-MCA cells; representative examples of overlays with the indicated
proteases and tetraspanins are shown; c precipitates of wt- and ko-MCA cell and TEX lysates with anti-MMP2, -MMP9, -uPAR and -TACE were
separated by SDS-PAGE, blotting membranes with anti-CD9, -CD151 and -Tspan8; representative examples are shown; d lysates of wt- and
ko-MCA tumors were fractionated by sucrose gradient centrifugation. After SDS-PAGE of fractions 1–4 and pooled fractions 5–8 and 9–12,
membranes were blotted with anti-MMP2, -MMP9, -uPAR and -TACE; representative examples are shown. MMP2, MMP9 and MMP14 preferentially
colocalize with Tspan8, TACE colocalizes with Tspan8 and CD151. However, in the absence of Tspan8 and CD151, proteases also associate with
CD9, which was confirmed by coIP. Density fractionation indicated impaired invasion being a sequel of the missing association of MMP2 and
MMP9 with Tspan8 and/or CD151 in TEM. Recovery of uPAR and TACE in light density fractions being not affected in Tspan8ko- and/or CD151ko-MCA
cells points towards TEM-independent associations
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transcription factor FOXO3, abundantly expressed in
BMC [63], also coimmunoprecipitated with Tspan8 and
CD151, coimmunoprecipitation being not significantly
altered by wt-TEX treatment (Fig. 7d).
Thus, reduced CD34, KIT and ALDH1/2 expression in
ko-BMC could indicate a minor contribution of Tspan8
and CD151 to early hematopoiesis. Impaired thrombo-
poiesis and erythropoiesis becomes aggravated Tspan8-
and CD151-independent by TEX. This also accounts for
expansion of CD11b + BMC. Reduced expression of
CD44 and CD62P, a megakaryocyte and endothelial cell
marker, corrected by wt-sExo, could contribute to im-
paired MCA homing into the BM, reduced TER119
expression may account for tumor-associated anemia.
The TEX-promoted CD11b upregulation in wt- and
ko-BMC likely is associated with a shift towards MDSC
or tumor growth-promoting M2 Mϕ. The reduced re-
covery of Kit+ and CD34+ cells in all ko BMC and coim-
munoprecipitation of KIT, MCSFR, CD184 and FOXO3
with Tspan8 and CD151 point towards Tspan8 and
CD151 supporting receptor-promoted hematopoietic cell
activation.
The impact of serum-Exo and TEX on angiogenesis
A contribution of sExo and TEX tetraspanins to angio-
genesis [64] was evaluated using EC-enriched cultures
from wt- and ko-lungs. EC tetraspanin expression is not
significantly affected by sExo or TEX. But, wt-TEX pro-
moted CD31 and CD34 expression in wt- and ko-EC,
CD144 in Tspan8ko-EC and CD106 and CD62P in
Fig. 7 The impact of Tspan8 and CD151 on hematopoiesis. The impact of Tspan8 and/or CD151 on hematopoietic cells and hematopoietic cell
modulation by wt-sExo or -TEX was evaluated in vitro using freshly harvested BMC, cultured for 48 h–72 h with sExo and TEX. a-c Flow-cytometry
analysis of tetraspanins, progenitor markers, growth factors and receptors, chemokines and receptors andFOXO3 after culture with wt-sExo or
wt- and ko-TEX; mean values of triplicates are shown, significant differences by coculture with wt-sExo are indicated by s (grey), by coculture
with wt- and ko-TEX by s (black), by coculture with wt-TEX by σ; d Untreated and wt-TEX-treated wt- and ko-BMC lysates were precipitated with
FOXO3, KIT, MCSFR, CD184, TER119 and CD11b and blotted with anti-CD9, -CD151 and -Tspan8. Wt-sExo rescued CD44 and CD62P expression in
ko-BMC. Wt- and ko-TEX provoked a slight reduction of ALDH1+, the megakaryocyte marker CD62P and the erythroid progenitor marker TER119
and promoted myeloid progenitor expansion, indicating that these effects were Tspan8- and CD151-independent; altered cytokine and receptor
expression was mostly restricted to wt-TEX treatment. Receptors and FOXO3 coimmunoprecipitated with Tspan8 and CD151. Only CD9
coimmunoprecipitated with TER119 and CD11b. The association of Tspan8 and CD151 with RTK and GPCR might support homing and settling
of MCA in the BM
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CD151ko-EC. Wt-TEX also promoted OPN, SDF1,
VEGFR2, FGFR3, EphA4 and CD184 in wt- and ko-EC
and wt-sExo sufficed for upregulation of OPN, VEGFR2
and EphA4 in ko-EC (Fig. 8a). Controlling for angio-
genic receptor expression in MCA cells confirmed
VEGFR2, VEGFR3 and EphA4 upregulation by wt-TEX
and correction in ko-MCA by wt-sExo. Lyve expression
was only promoted in CD151ko-MCA by wt-sExo and
-TEX (Fig. 8b).
Confocal microscopy accredited pronounced CD184
colocalization with Tspan8 and CD151 in wt-sExo-treated
CD151ko- and Tspan8ko-EC. Wt-TEX also promoted
pronounced CD184 colocalization with Tspan8 and
CD151 in wt-EC (Fig. 8c). Similar findings accounted for
EphA4 and VEGFR2, although the impact of sExo and
TEX was weaker due to colocalization also in the absence
of sExo or TEX (Fig. 8d, e).
Evaluating the impact of sExo and TEX on expression
and colocalization of VEGFR3 in wt-, Tspan8ko- and
CD151ko-MCA indicated strong colocalization with
Tspan8 in TEX-treated wt- and CD151ko-MCA, but less
pronounced with CD151 in Tspan8ko-MCA, suggesting
preferential colocalization of VEGFR3 with Tspan8 (data
not shown). CoIP of VEGFR2, VEGFR3, FGFR3 and
EphA4 with CD151 and Tspan8 in MCA-lysates con-
firmed VEGFR2 preferentially associating with CD151,
and VEGFR3 with Tspan8. EphA4 and FGFR3 associate
with both. Notably, in most instances, coimmunopreci-
pitation is stronger after coculture with wt-TEX (Fig.
8f ).
These analyses revealed defects in angiogenesis being
partly host- and partly tumor-related. Defects in RTK
expression can mostly be rescued by TEX, sExo are
more efficient in stimulating angiogenic factor expres-
sion. The increased recovery of Tspan8 and CD151 in
wt-sExo- or -TEX-treated ko cells was unexpected and
might indicate a direct transfer from sExo/TEX into the
tumor cell, which requires further exploration.
Tspan8ko-, CD151ko- and dbko-MCA tumors poorly
disseminate in the autochthonous host, which relies on
the contribution of Tspan8 and CD151 to TEX biogen-
esis particularly the recruitment of associated proteins
that account for adhesion, migration, invasion and
(lymph)angiogenesis. Mitigated defects in ko tumor cell
dissemination grown in wt-mice are based on the
support of angiogenesis by host Exo.
Discussion
There is ample evidence for the importance of TEX in
tumor progression and angiogenesis [65] with a sug-
gested feedback by host-derived Exo. We approached
the topic using Tspan8ko and/or CD151ko hosts and
MCA tumors, based on the following considerations.
First, tetraspanins act as molecular facilitators by
associating with a multitude of proteins that become
assembled in special glycolipid-enriched membrane
domains, TEM [17, 66, 67]. Second, tetraspanins are
engaged in Exo biogenesis such that the complete arma-
ment of TEM is transferred into Exo [43]. Third, tetra-
spanin complexes contribute to target binding and
uptake [15]. Fourth, both Tspan8 and CD151 promote
angiogenesis and tumor progression [21, 41, 68–70].
Last, there are hints that CD151 and Tspan8 may use
different partners and pathways to achieve alike effects
[21].
The model confirmed metastasis-promotion of Tspan8
and CD151 as well as a host Tspan8 / CD151 contribu-
tion. Wt MCA tumors poorly disseminate in Tspan8ko
and/or CD151ko hosts and Tspan8ko- and/or
CD151ko-MCA poorly disseminate in the autochthon-
ous host, whereas dissemination is enhanced in the wt
host. We will discuss our interpretations after outlining
the limits of the experimental system.
Strengths and limitations of the Tspan8ko / CD151ko
criss-cross model
The potency of the model, outlined above, also accounts
for the MCA tumors, though CD151 expression was not
high and Tspan8 expression was low. Nonetheless,
Tspan8- and CD151 were enriched in Exo compared to
parental cells [9].
However, interpretations need to take into account
some limitations. First, cells deliver different types of
Exo [7, 9, 13, 71]. To incorporate this aspect, purified
Exo would have to be sorted according to selective
markers of caveolae-, raft-, lipid- and GOLGI-derived
Exo. Due to a shortage of selective markers, separating
exclusively TEM-derived Exo was technically not feas-
ible. In addition, tetraspanins are not exclusively located
in TEM and the tetraspanin composition in individual
TEM / TEM-derived Exo varies [72]. As all types of Exo
share lipid-ordered membranes, working with a pool of
Exo prohibited controlling coimmunoprecipitation after
mild lysis by density distribution. To take this into
account, cell lysate proteins recovered at a different
density from TEM-located tetraspanins were considered
as not being TEM-derived. For a third, model-related
phenomenon, two interpretations cannot be mutually
excluded. A high number of proteins colocalizes and
coimmunoprecipitates with CD9, colocalization /
coimmunoprecipitation being frequently, but not consist-
ently stronger in Tspan8ko or CD151ko cells. In the latter
case, replacement of Tspan8 / CD151 by CD9 could be
envisaged. Alternatively, by the high abundance of CD9
compared to CD151 and Tspan8, CD9-TEM and
CD9-TEM-derived Exo may be dominating.
In brief, working with a pool of Exo prohibits an
unequivocal assignment to Tspan8, CD151 or additional
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tetraspanins, particularly CD9. Thus, with few excep-
tions, the suggestion of divergent/additive activities of
Exo Tspan8 and CD151 are based on different effects
seen inTspan8ko and CD151ko cells and on stronger ef-
fects in dbko than Tspan8ko or CD151ko cells and Exo.
Tspan8, CD151 and Tspan8-/CD151-complexes in tumor
progression
Distinct to epithelial cancer induction in CD151ko mice
[73], MCA tumor induction was not affected by a deficit
in Tspan8 or CD151 [41]. No major changes in common
tumor markers being observed, the more rapid local
growth of a dbko-MCA tumor fortifies this suggestion.
CD151 is not essentially linked to tumor induction.
Nonetheless, CD151 may contribute to oncogenesis in
epithelial tumors via the crosstalk with a surround-
ing that promotes integrin activation initiating either
FAK and downstream signaling or RTK activation
[29, 74–78].
On the other hand, a Tspan8ko and a CD151ko
affected anchorage-independent growth, which was
partially rescued by wt-TEX. Anoikis execution, initiated
via perturbation of mitochondria or death receptor acti-
vation, proceeds via activation of caspases and down-
stream pathways with activation of endonucleases and
DNA fragmentation. Anoikis resistance being vital for
tumor progression and metastasis formation, tumor cells
use several pathways to circumvent anoikis. A shift to-
wards anoikis-protecting integrins was not observed
(79), only in CD151ko/dbko MCA CD151 expression
was reduced and rescued in wt and Tspan8ko mice. Ad-
hesion to the ECM can promote FAK, Src and ILK acti-
vation which promote PI3K/Akt and MAPK pathway
activation (79), seen in Tspan8kd and CD151kd pancre-
atic adenocarcinoma (40), but not in the ko MCA. Alter-
natively, integrins mediate growth factor receptor
activation [79, 80]. Though EGFR and MET expression
were not affected, expression of several RTK including
TGFβR, VEGFR2 and EphA4 were reduced in Tspan8ko
and/or CD151ko MCA, which could have added to re-
duced apoptosis resistance. Finally, EMT contributes to
anoikis resistance [79, 81], the EMT phenotype being
accompanied by a reduction of E-cadherins / β-catenin,
upregulation of the mesenchymal markers vimentin and
FN and MMP activation. Central for EMT induction are
the transcription factors Snail, ZEB1/2, Twist, NFκB and
HIF [79, 82].We only noted a slight reduction of
vimentin in Tspan8ko and CD151ko MCA and a reduc-
tion in FN expression, stronger in CD151ko- than
Tspan8ko-MCA. Wt-TEX merely sufficed for a signifi-
cant rescue of FN in Tspan8ko MCA. Expression of the
central EMT-related transcription factors was not affected
by the Tspan8ko and/or CD151ko and remained stable in
the presence of wt-TEX. Instead, expression of Nanog and
NOTCH that can contribute to EMT [83, 84] was reduced
in Tspan8ko and CD151ko MCA and was rescued by
wt- and ko-TEX. The latter suggests Tspan8- and
CD151-independent TEX components accounting for
the rescue.
In brief, Tspan8 and CD151 do not significantly
contribute to drug resistant, only proliferation of the
dbko-MCA line being more sensitive to cisplatin treat-
ment. As PI3K/Akt pathway activation (data not shown)
and pBAD and BclXl expression were reduced in
Tspan8ko- and dbko-MCA cells and corrected by
wt-TEX, mitigated PI3K/Akt activation likely sufficed for
impaired proliferation, but not for affecting mitochon-
drial integrity or promoting DNA degradation. Also
excluding a major contribution of MCA Tspan8 and
CD151 to EMT, a rescue of NOTCH and Nanog by TEX
being Tspan8- and CD151-independent, we suggest
reduced anchorage-independent growth of Tspan8ko
and CD151ko MCA to rely on multiple factors that
partly are Tspan8- and CD151-independent.
Poor migration of Tspan8ko- and CD151ko-tumors on
collagen I, collagen IV, LN111 and LN332 is due to dis-
torted CD49c-Tspan8 and CD56- and CD106-CD151 co-
operation, expression of these adhesion molecules being
slightly reduced in ko-MCA cells and TEX. However,
CD49c and CD49f, preferred LN-binding integrin part-
ners of CD151 and Tspan8 [40, 85–87], also precipitated
with CD9 in the absence of Tspan8 and/or CD151. A
(See figure on previous page.)
Fig. 8 Tspan8, CD151 and angiogenesis in ko mice and ko MCA tumors. Dispersed lung cells were cultured for 3wk-4wk to enrich and expand
EC. EC were cocultured with wt-sExo or wt- and ko-TEX for 48 h–72 h. a EC flow-cytometry analysis of tetraspanins, EC markers, chemokines and
angiogenic receptors including representative examples and (b) of MCA angiogenic receptor; a,b mean % stained cells (3 assays), significant
differences between wt- and ko-EC or -MCA cells: *, significant differences by coculture with sExo: s (grey) or TEX: s (black); c-e confocal
microscopy of wt-, Tspan8ko-, and CD151ko-EC cultured in the absence or presence of wt-sExo or -TEX and stained with anti-Tspan8 or anti-
CD151 and counterstained with (c) anti-CD184, d anti-EphB4, e anti-VEGFR2, single staining and overlays are shown (scale bar: 10 μm); f untreated
and wt-TEX-treated wt- and ko-MCA lysates were precipitated with anti-VEGFR2, -VEGFR3, -FGFR3 and EphA4. Dissolved precipitates were blotted
with anti-Tspan8 or anti-CD151. Representative WB examples are shown. Ko-EC express CD31, CD34, OPN, VEGFR2, and EphA4 at a reduced level;
in CD151ko-EC additionally CD106 and CD62P expression is reduced. Wt-sExo promote OPN, VEGFR2 and EphA4 expression in ko-EC; wt-TEX
activate EC marker, OPN, SDF1, VEGFR2, EphA4 and CD184 expression in wt- and ko-EC. In ko-MCA cells, wt-sExo and -TEX support VEGFR2,
VEGFR3 and EphA4 expression. Upregulated expression, accompanied by colocalization and coimmunoprecipitation, might well account for
Tspan8- and CD151-TEX promoted EC activation
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contribution of CD9 to migration [88–90] was suggested
to rely on clustering associated adhesion molecules and
concomitantly reducing TACE activation [91]. However,
although CD49c and CD9 shifted to heavier fractions
particularly in dbko cell lysates, in wt lysates, too, a
higher proportion of CD9 than of Tspan8 and CD151
was recovered in heavier fractions. We interpret the
finding indicating CD9 being only partly located in
TEM. Accordingly, TEX CD9-integrin complexes might
differ from TEM-derived complexes. Whether non-TEM
CD9-integrin complexes substitute for Tspan8 and
CD151 or account for distinct adhesion, remains to be
answered. Only dbko MCA showing pronounced migra-
tion on FN-coated plates suggests an engagement of
CD9-associated integrins. However, depending on the
integrin profile, CD9 may also inhibit FN binding [92].
CD56 and CD106 selectively coimmunoprecipitated
with CD151. In cancer, CD151 and CD56 / CD106 are
jointly upregulated [93, 94], CD106 upregulation pro-
ceeding via the impact of CD151 on MET signaling [94],
CD151-dependent activation of MET signaling in pro-
moting motility being also described for EC [94], and a
CD151-CD49c or -CD49f complex promotes motility of
breast cancer cells via MET activation [74], which may
also account for CD56. Notably, the selective shift of
CD56 and CD106 towards heavier sucrose gradient
fractions in CD151ko and dbko cells indicates that
CD151 and Tspan8 are partly recovered in distinct TEM
domains and, accordingly, will be separately recruited
into EE / TEX.
Tspan8 and CD151 also distinctly contribute to inva-
sion. Tspan8ko- and CD151ko-MCA are poorly invasive,
matrigel penetration of dbko-MCA being further re-
duced. Coculture of Tspan8ko- and CD151ko-MCA cells
with wt- and ko-TEX confirmed strongly reduced effi-
cacy of ko-TEX in restoring invasiveness compared to
wt-TEX. This relies on the association of Tspan8 and
CD151 with proteases. MMP2 and MMP9 are most
strongly reduced in Tspan8ko-TEX, recovery of the
membrane-anchored proteases TACE, ADAM10 and
MMP14 is more severely affected in CD151ko-TEX. Su-
crose gradient fractionation indicated a shift of MMP2
and MMP9 to heavier fractions in Tspan8ko-, but not of
uPAR and TACE in CD151ko-lysates, indicating CD151
associating with uPAR and ADAM10 preferentially in
Non-TEM internalization domains. The GPI-anchored
uPAR can associate with IGF2R (insulin like growth
factor 2 receptor), which promotes internalization [95].
uPAR also associates with LRP-1 (LDL receptor related
protein 1), which recruits VEGFR2 and fosters internal-
ization upon ligand binding [96]. Furthermore, cathepsin B
and uPAR were described to regulate LN332-bound
CD151-CD49c/CD29 complex expression in glioma,
the components of this multimeric complex
coimmunoprecipitating [97]. Downregulation of cathepsin
B or uPAR is accompanied by reduced CD151 and
CD49c/CD29 expression and downstream FAK, src and
paxillin phosphorylation [97]. TACE is partly recovered in
TEM [98] and coimmunoprecipitates with CD151. It was
described that palmitoylated Tspan12 associates with
ADAM10, enhances ADAM10 prodomain maturation
and amyloid precursor protein shedding [99]. We noted
coimmunoprecipitation of CD151 with TACE, the major
sheddase for tumor necrosis factor α (TNFα), EGFR
ligands, CD62L and the IL6R [100]. Opposing expectation,
uPAR and TACE were not shifted to heavier density
fractions in CD151ko MCA. Thus, uPAR and TACE
recruitment into TEX may not proceed via internalized
TEM. Irrespective of TEX recruitment, the findings are in
line with protease upregulation/activation relying on
tetraspanin-associations, where activation of integrins and
RTK can drive protease expression [22, 44, 101, 102].
Taken together, Tspan8 and CD151 not significantly
contributing to apoptosis resistance and EMT of
MCA tumors argues against an involvement in onco-
genicity. However, Tspan8 and CD151 support migra-
tion and invasion, which relies on clustering adhesion
molecules and proteases in invagination prone mem-
brane domains, fostering release in TEX. Tspan8
preferably associates with integrins, MMP2 and
MMP9; CD151 primarily cooperates with CAMs and
membrane-anchored proteases, which accounts for
the additive defects in dbko-MCA. Delivery of dis-
tinct TEX, only part of them being TEM-derived
and/or harvesting Tspan8 and CD151 explains the
gradual rather than on/off effects of Tspan8 and
CD151 deletion.
Tspan8, CD151 and the crosstalk between tumor and
host
Impaired settlement of Tspan8ko- and CD151ko-MCA
in the autochthonous BM, partly restored in the wt-host,
suggested a contribution of sExo/TEX-Tspan8 and
-CD151 to tumor cell settlement in the BM [103, 104]
and to deviation of hematopoiesis [53, 105].
A slight reduction of CD9, CD63 and early
hematopoietic progenitors (KIT+, CD34+) in Tspan8ko-
and CD151ko-BMC was not corrected or aggravated by
coculture with wt-sExo or wt-TEX. We interpret the
reduced recovery of CD9, CD63 and KIT in ko mice
indicating a contribution of Tspan8 and CD151 to early
hematopoiesis maintenance as described for CD9 and
CD63 in embryonic development [61, 106]. Not yet
answered for Tspan8 and CD151, this suggestion re-
quires follow-up studies. Furthermore, CD9 and CD151
are engaged in thrombopoiesis, CD9 also affects myelo-
poiesis and CD151 erythropoiesis. These activities essen-
tially depend on the association with integrins and
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include the crosstalk with the ECM and mesenchymal
stem cells [107–111]. We noted reduced CD62P,
TER119 and GR1 expression in Tspan8ko and CD151ko
BMC. With the exception of CD62P and CD44 (only
CD151ko), these defects were not corrected by wt-sExo.
Instead, wt- and ko-TEX promoted a further reduction
of Ter119, CD62P and an expansion of CD11b. Thus, the
impact of TEX on deviation of committed hematopoietic
progenitors is Tspan8- and CD151-independent. On the
other hand, reduced expression of FOXO3, the central
transcription factor in hematopoiesis [112], and KIT,
MCSFR and CD184 receptors were mostly affected by wt-,
but not by ko-TEX. These molecules coimmunoprecipitate
with CD151 and Tspan8, implying the Tspan8- or
CD151-associations assisting expression/activation. The
finding strengthens the importance of the interplay between
tetraspanins and receptor kinases also in non-transformed
cells. Finally, wt-sExo may well contribute to MCA settle-
ment in the BM by promoting adhesion- and
homing-facilitating higher CD62P and CD44 expression
[113, 114]. Wt-TEX can support this process by CD184
induction, possibly in concert with additional chemokine
receptors [115, 116]. A direct contribution to CD184
expression was described for CD9, CD184 upregulation
modulating megakaryocyte motility and leukemia dissemin-
ation [107, 117]. Furthermore, a CD63 mutant inhibits
HIV1 entry by disrupting the trafficking of CD184 to the
plasma membrane [118]. Though the engagement of tetra-
spanins in GPCR activation is not fully elucidated, GPCR
engagement in membrane lipid microdomains / rafts and
Exo contributes to the dynamic of intercellular communi-
cation including cytoskeleton arrangement and signaling
[119–121], where coimmunoprecipitation points towards
Tspan8 and CD151 contributing to CD184-promoted
homing and settlement of MCA tumor cells within
the BM environment.
In brief, a suggested contribution of Tspan8 and
CD151 to early hematopoiesis requires further explor-
ation. TEX-promoted impaired erythropoiesis, thrombo-
poiesis and immune deviation relies not or only partly
on Tspan8 and CD151. However, Exo/TEX Tspan8 and
CD151 assist hematopoiesis maintenance by growth
factor receptor stabilization and tumor cell homing by
adhesion molecule clustering and chemokine receptor
upregulation.
Tspan8ko- and CD151ko-EC revealed defects in OPN
[122], VEGFR2 [123] and EphA4 [124] expression.
CD151ko-EC additionally showed reduced CD106 and
CD62P expression [68, 125, 126]. These defects were not
only coped by wt-TEX, but expression of CD31, CD34,
CD62P, OPN, SDF1, VEGFR2, VEGFR3, FGFR3, EphA4
and CD184 was stimulated. Wt-sExo supported OPN,
SDF1, VEGFR2 and EphA4 upregulation. Similar “cor-
rections” being not seen after coculture with dbko-TEX
and rarely with Tspan8ko- or CD151ko-TEX (data not
shown) confirms the share of sExo/TEX-Tspan8 and
-CD151 to angiogenesis. The contribution of tetraspanin
microdomains via the association with e.g. CD54,
CD106 and CD62P on EC was repeatedly described [68].
Thus, CD63, CD82 and CD151 bridge VEGFR2 on EC
via CD29, which initiates via downstream signaling the
response to VEGF [127, 128]. CD9 in association with
CD29 and CD61 also promotes EC migration [129] and
EWI-F (CD9P-1) inhibits angiogenesis by downregula-
tion of CD151 and CD9 [130], the contribution of
CD151 also relying on its palmitoylation, which stimu-
lates PI3K/Akt and MAPK signaling [131]. Furthermore,
CD9 promotes angiogenesis in response to fibroblast
growth factor (FGF) by linking JAM to CD51/CD61-ini-
tiated signaling [132] and CD151 fosters angiogenesis on
LN substrates, Akt, e-NOS, Rac and Cdc42 becoming
activated via CD151-associated integrins [133]. In
addition, CD151 can promote EC proliferation, migra-
tion and tube formation by stimulating MET signaling
[94]. Also and of special interest, CD151-CD49f/CD29
complexes instruct embryonic stem cells towards
differentiation into EC [31]. Tspan8 TEX-induced angio-
genesis is accompanied by upregulation of Tspan8, von
Willebrand factor (vWF), CXCL5, macrophage migration
inhibitory factor (MIF) and CCR1 in EC. Coculture with
Tspan8-CD49d TEX promotes EC proliferation and
sprouting and EC progenitor maturation [39, 70].
Previous studies in Tspan8ko and CD151ko mice con-
firmed impaired angiogenesis and suggested a contribu-
tion due to adhesion molecules not being assembled in
Tspan8ko and CD151ko TEM, which resulted in im-
paired adhesion and migration [41]. Notably, tetraspanin
webs are also engaged in lymphangiogenesis. CD9
promotes lymphangiogenesis by a linkage to VEGFR3
via CD49e or integrin α9 [47]. Lymphangiogenesis
induction in prostate cancer essentially depends on high
CD151 expression [45].
Taken together, CD9, Tspan8 and CD151 contribute to
EC/lymphatic EC activation, proliferation and tube
formation. This relies in part on direct activation via
palmitoylated tetraspanins, but mostly on cellular or
matrix protein ligation of associated CAMs, selectins
and integrins, which in turn account for angiogenic
receptor recruitment and internalization-promoted acti-
vation. Due to the recruitment of TEM microdomains
into Exo, deficits of Tspan8ko and CD151ko EC can
mostly be balanced by sExo, whereas TEX fortify
(lymph)angiogenesis.
Finally, Tspan8 and CD151 assist angiogenic receptor
expression in MCA tumor cells and TEX, VEGFR2 [127,
128] being reduced in Tspan8ko and CD151ko, VEGFR3
[41, 45, 47, 48] and EphA4 [124] being more strongly re-
duced in Tspan8ko- and dbko-MCA. VEGFR2, EphA4
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and Lyve are rescued by wt-sExo and wt-TEX [134],
VEGFR3 is rescued by wt-TEX. The angiogenesis-related
receptors colocalize in EC and coimmunoprecipitate in
MCA with Tspan8 (preferentially VEGFR3) and CD151
(especially VEGFR2). Coimmunoprecipitation being
strengthened after coculture with TEX is in line with the
cooperation of tetraspanins with RTK [135–137]. The
contribution of Ephrin receptors relies on acting as a
hub for internalization and activation of RTK [138, 139],
a connection to tetraspanins being described for the
entry of hepatitis C virus into liver cells, where up-
take by a CD81-claudin1 complex is facilitated by
EphA2 that supports internalization and activation of
the EGFR [140].
Deficits in angiogenic receptor expression in Tspan8ko
and CD151ko MCA being partly corrected by wt-sExo
and more efficiently wt-TEX suggests that
tetraspanin-promoted RTK upregulation in MCA tu-
mors proceeds like in EC via tetraspanin-associated
adhesion molecules. The tetraspanin-integrin-RTK com-
plex being transferred into TEX, both binding- and
uptake-initiated target activations are conceivable.
Conclusion
The criss-cross evaluation of wt, Tspan8ko, CD151ko
and dbko MCA tumor and host cells confirmed tumor-
and host-derived Tspan8 and CD151 additively assisting
metastasis, defects in cooperation with adhesion mole-
cules, proteases, RTK and GPCR being only partly over-
lapping. However, due to wt-sExo and wt-TEX being not
sorted according to their origin from Tspan8 or CD151
TEM, the distinct contributions of Tspan8 versus CD151
to tumor progression occasionally became veiled in Exo.
Nonetheless, we could demonstrate metastasis-promoting
Tspan8 and CD151 activities to proceed at multiple levels
due to Tspan8 and CD151 cooperating with different part-
ners in distinct cell populations. Support of tumor cell
migration and invasion is based on adhesion molecule
and protease associations. The tetraspanin-adhesion
molecule and -protease complexes being transferred
into TEX, wt-TEX treatment copes with ko-MCA def-
icits. TEX-promoted deviation of hematopoietic pro-
genitor maturation relies not or merely to a minor
extent on Tspan8 or CD151. Instead, wt-TEX facili-
tate MCA recruitment and settlement in the BM by
associating with adhesion molecules and chemokine
receptors. Angiogenesis mostly affected in CD151ko-
and lymphangiogenesis in Tspan8ko-MCA and -EC is
reestablished by sExo and boosted by TEX, activation
of GPCR and RTK via tetraspanin-associated adhesion
molecules being of central importance.
The common theme is the “facilitator” role of tetraspa-
nins [141] and the engagement of TEM in Exo-biogenesis
and -binding [142]. Though open questions remain, the
poor responsiveness of dbko-MCA suggests a joint block-
ade of Tspan8 and CD151 efficiently hampering several
exosome-provided prerequisites for tumor progression.
Additional file
Additional file 1: Table S1. Primers. Table S2. Reagents. Figure S1.
Characterization of MCA tumors, bone marrow cells and endothelial cells
from Tspan8ko- and/or CD151ko-mice. Figure S2. Tspan8- and CD151-
dependence of TEX and sExo delivery and uptake. Figure S3. Ex vivo
analysis of tetraspanin, adhesion molecule and angiogenic factor expres-
sion in MCA tumors. Figure S4. TEX and apoptosis resistance of wt- and
ko-MCA tumor cells. Figure S5. The impact of TEX on EMT. Figure S6.
TEX proteases and invasion of Tspan8ko and/or CD151ko MCA cells.
Figure S7 Flow-cytometry examples on the impact of sExo and TEX
uptake on BMC subpopulations. (PDF 4883 kb)
Abbreviations
BMC: Bone marrow cells; coll: Collagen; dbko: Tspan8ko/CD151ko;
EC: Endothelial cells; ECM: Extracellular matrix; EE: Early endosomes;
Exo: Exosomes; FAK: Focal adhesion kinase; FGF: Fibroblast growth factor;
FITC: Fluorescence isothiocyanate; FN: Fibronectin; GPCR: G-protein-coupled
receptor; GPI: Glycosylphosphatidylinositol; HGF: Hepatocyte growth factor;
IP: Immunoprecipitation; kd: Knockdown; ko: Knockout; LB: Latex beads;
LN: Laminin; LNC: Lymph node cells; LRP: Low density lipoprotein receptor-
related protein; MCA: Methylcholanthrene; MCSFR: Macrophage colony
stimulating factor receptor; MDSC: Myeloid-derived suppressor cells;
MIF: Macrophage migration inhibitory factor; MMP: Metalloproteinase;
MVB: Multivesicular bodies; OPN: Osteopontin; PBL: Peripheral blood
leukocytes; RTK: Receptor tyrosine kinase; sc: Subcutaneously; sExo: Serum-
Exo; TEM: Tetraspanin-enriched membrane microdomains; TEX: Tumor
exosomes; TF: Tissue factor; ThbSp: Thrombospondin; TNF: Tumor necrosis
factor; VEGF: Vascular endothelial growth factor; vWF: Von Willebrand factor;
WB: Western blot; wt: Wild type
Acknowledgements
We most cordially thank Leonie K Ashman, School of Biomedical Sciences
and Pharmacy, University of Newcastle, Callaghan, Australia, for providing the
CD151ko mice.
Funding
This investigation was supported by the German Cancer Research Aid (MZ,
No 110836) and the China Scholarship Council (KZ, CSC 201608080054).
Availability of data and materials
Raw data will be provided upon request.
Authors’ contributions
KZ, ZW performed and analyzed experiments, CP helped and supervised the
animal experiments and corrected the manuscript draft, TH corrected the
manuscript draft, MZ planned the experiments, helped with experiment
performance and analysis and wrote the manuscript. All authors read and
approved the final manuscript.
Ethics approval
Animal experiments were approved by the Government of Baden-Wuerttemberg,
Germany and were carried out in accordance with EU Directive 2010/63/EU.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Zhao et al. Journal of Experimental & Clinical Cancer Research          (2018) 37:312 Page 20 of 23
Author details
1Pancreas Section, University Hospital of Surgery, Ruprecht-Karls-University,
Heidelberg, Germany. 2Interdisciplinary Neurobehavioral Core, Institute of
Pharmacology, Ruprecht-Karls-University, Heidelberg, Germany. 3Present
Address: Department of Oncology, First Affiliated Hospital of Guangdong
Pharmaceutical University, Guangdong, China.
Received: 17 September 2018 Accepted: 14 November 2018
References
1. McAllister SS, Weinberg RA. The tumour-induced systemic environment as a
critical regulator of cancer progression and metastasis. Nat Cell Biol.
2014;16:717–27.
2. Gacche RN, Meshram RJ. Targeting tumor micro-environment for design
and development of novel anti-angiogenic agents arresting tumor growth.
Prog Biophys Mol Biol. 2013;113:333–54.
3. Saleem SN, Abdel-Mageed AB. Tumor-derived exosomes in oncogenic
reprogramming and cancer progression. Cell Mol Life Sci. 2015;72:1–10.
4. Sato S, Weaver AM. Extracellular vesicles: important collaborators in cancer
progression. Essays Biochem. 2018;62:149–63.
5. Whiteside TL. Tumor-Derived Exosomes and Their Role in Cancer
Progression. Adv Clin Chem. 2016;74:103–41.
6. Milane L, Singh A, Mattheolabakis G, Suresh M, Amiji MM. Exosome mediated
communication within the tumor microenvironment. J Control Release. 2015;
219:278–94.
7. Kowal J, Tkach M, Théry C. Biogenesis and secretion of exosomes. Curr Opin
Cell Biol. 2014;29:116–25.
8. French KC, Antonyak MA, Cerione RA. Extracellular vesicle docking at the
cellular port: Extracellular vesicle binding and uptake. Semin Cell Dev Biol.
2017;67:48–55.
9. Xu R, Greening DW, Zhu HJ, Takahashi N, Simpson RJ. Extracellular vesicle
isolation and characterization: toward clinical application. J Clin Invest.
2016;126:1152–62.
10. Kalluri R. The biology and function of exosomes in cancer. J Clin Invest.
2016;126:1208–15.
11. Record M, Carayon K, Poirot M, Silvente-Poirot S. Exosomes as new vesicular
lipid transporters involved in cell-cell communication and various
pathophysiologies. Biochim Biophys Acta. 2014;1841:108–20.
12. Huleihel L, Hussey GS, Naranjo JD, Zhang L, Dziki JL, Turner NJ, et al.
Matrix-bound nanovesicles within ECM bioscaffolds. Sci Adv. 2016;2:e1600502.
13. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular
interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol.
2014;30:255–89.
14. Mazurov D, Barbashova L, Filatov A. Tetraspanin protein CD9 interacts with
metalloprotease CD10 and enhances its release via exosomes. FEBS J. 2013;
280:1200–13.
15. Rana S, Yue S, Stadel D, Zöller M. Toward tailored exosomes: the exosomal
tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol.
2012;44:1574–84.
16. Stipp CS, Kolesnikova TV, Hemler ME. Functional domains in tetraspanin
proteins. Trends Biochem Sci. 2003;28:106–12.
17. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev
Mol Cell Biol. 2005;6:801–11.
18. Bassani S, Cingolani LA. Tetraspanins: Interactions and interplay with
integrins. Int J Biochem Cell Biol. 2012;44:703–8.
19. Berditchevski F, Odintsova E. Tetraspanins as regulators of protein trafficking.
Traffic. 2007;8:89–96.
20. Yáñez-Mó M, Gutiérrez-López MD, Cabañas C. Functional interplay between
tetraspanins and proteases. Cell Mol Life Sci. 2011;68:3323–35.
21. Yue S, Zhao K, Erb U, Rana S, Zöller M. Joint features and complementarities
of Tspan8 and CD151 revealed in knockdown and knockout models.
Biochem Soc Trans. 2017;45:437–47.
22. Sadej R, Grudowska A, Turczyk L, Kordek R, Romanska HM. CD151 in cancer
progression and metastasis: a complex scenario. Lab Investig. 2014;94:41–51.
23. Zöller M. Tetraspanins: push and pull in suppressing and promoting
metastasis. Nat Rev Cancer. 2009;9:40–55.
24. Hasegawa M, Furuya M, Kasuya Y, Nishiyama M, Sugiura T, Nikaido T, et al.
CD151 dynamics in carcinoma-stroma interaction: integrin expression,
adhesion strength and proteolytic activity. Lab Investig. 2007;87:882–92.
25. Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, Ding ZB, et al. CD151 amplifies
signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal
transition in HCC cells. Gastroenterology. 2011;140:1629–41.
26. Berditchevski F. Complexes of tetraspanins with integrins: more than meets
the eye. J Cell Sci. 2001;114:4143–51.
27. Novitskaya V, Romanska H, Kordek R, Potemski P, Kusińska R, Parsons M, et
al. Integrin α3β1-CD151 complex regulates dimerization of ErbB2 via RhoA.
Oncogene. 2014;33:2779–89.
28. Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, et al. Integrin-associated
CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
Neoplasia. 2012;14:678–89.
29. Li Q, Yang XH, Xu F, Sharma C, Wang HX, Knoblich K, et al. Tetraspanin
CD151 plays a key role in skin squamous cell carcinoma. Oncogene.
2013;32:1772–83.
30. Takeda Y, Li Q, Kazarov AR, Epardaud M, Elpek K, Turley SJ, et al.
Diminished metastasis in tetraspanin CD151-knockout mice. Blood.
2011;118:464–72.
31. Toya SP, Wary KK, Mittal M, Li F, Toth PT, Park C, et al. Integrin α6β1
Expressed in ESCs Instructs the Differentiation to Endothelial Cells. Stem Cells.
2015;33:1719–29.
32. Akiel MA, Santhekadur PK, Mendoza RG, Siddiq A, Fisher PB, Sarkar D.
Tetraspanin 8 mediates AEG-1-induced invasion and metastasis in
hepatocellular carcinoma cells. FEBS Lett. 2016;590:2700–8.
33. Fang T, Lin J, Wang Y, Chen G, Huang J, Chen J, et al. Tetraspanin-8
promotes hepatocellular carcinoma metastasis by increasing ADAM12m
expression. Oncotarget. 2016;7:40630–43.
34. Park CS, Kim TK, Kim HG, Kim YJ, Jeoung MH, Lee WR, et al. Therapeutic
targeting of tetraspanin8 in epithelial ovarian cancer invasion and
metastasis. Oncogene. 2016;35:4540–8.
35. Pan SJ, Wu YB, Cai S, Pan YX, Liu W, Bian LG, et al. Over-expression of
tetraspanin 8 in malignant glioma regulates tumor cell progression.
Biochem Biophys Res Commun. 2015;458:476–82.
36. Pan SJ, Zhan SK, Pan YX, Liu W, Bian LG, Sun B, et al. Tetraspanin 8-rictor-
integrin α3 complex is required for glioma cell migration. Int J Mol Sci.
2015;16:5363–74.
37. Ailane N, Greco C, Zhu Y, Sala-Valdés M, Billard M, Casal I, et al. Effect of an
anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth
in a nude mouse model. Front Physiol. 2014;5:364.
38. Claas C, Seiter S, Claas A, Savelyeva L, Schwab M, Zöller M. Association
between the rat homologue of CO-029, a metastasis-associated tetraspanin
molecule and consumption coagulopathy. J Cell Biol. 1998;141:267–80.
39. Gesierich S, Berezovskiy I, Ryschich E, Zöller M. Systemic induction of the
angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res. 2006;
66:7083–94.
40. Yue S, Mu W, Erb U, Zöller M. The tetraspanins CD151 and Tspan8 are
essential exosome components for the crosstalk between cancer initiating
cells and their surrounding. Oncotarget. 2015;6:2366–84.
41. Zhao K, Erb U, Hackert T, Zöller M, Yue S. Distorted leukocyte migration,
angiogenesis, wound repair and metastasis in Tspan8 and Tspan8/CD151
double knockout mice indicate complementary activities of Tspan8 and
CD51. Biochim Biophys Acta. 2018;1865:379–91.
42. Wright MD, Geary SM, Fitter S, Moseley GW, Lau LM, Sheng KC, et al.
Characterization of mice lacking the tetraspanin superfamily member
CD151. Mol Cell Biol. 2004;24:5978–88.
43. Andreu Z, Yáñez-Mó M. Tetraspanins in extracellular vesicle formation and
function. Front Immunol. 2014;5:442.
44. Berditchevski F, Odintsova E. ErbB receptors and tetraspanins: Casting the
net wider. Int J Biochem Cell Biol. 2016;77(Pt A):68–71.
45. Detchokul S, Newell B, Williams ED, Frauman AG. CD151 is associated with
prostate cancer cell invasion and lymphangiogenesis in vivo. Oncol Rep.
2014;31:241–7.
46. Hemler ME. Tetraspanin proteins promote multiple cancer stages. Nat Rev
Cancer. 2014;14:49–60.
47. Iwasaki T, Takeda Y, Maruyama K, Yokosaki Y, Tsujino K, Tetsumoto S, et al.
Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in
vitro. J Biol Chem. 2013;288:2118–31.
48. Oh HH, Park KJ, Kim N, Park SY, Park YL, Oak CY, et al. Impact of KITENIN
on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
Oncol Rep. 2016;35:253–60.
49. Zhang F, Kotha J, Jennings LK, Zhang XA. Tetraspanins and vascular
functions. Cardiovasc Res. 2009;83:7–15.
Zhao et al. Journal of Experimental & Clinical Cancer Research          (2018) 37:312 Page 21 of 23
50. Boyiadzis M, Whiteside TL. The emerging roles of tumor-derived exosomes
in hematological malignancies. Leukemia. 2017;31:1259–68.
51. Liu Y, Gu Y, Cao X. The exosomes in tumor immunity. Oncoimmunology.
2015;4:e1027472.
52. Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G,
et al. Melanoma exosomes educate bone marrow progenitor cells toward a
pro-metastatic phenotype through MET. Nat Med. 2012;18:883–91.
53. Zöller M. Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good
and the Bad in Cancer and Autoimmune Disease. Front Immunol. 2018;9:137.
54. Colak S, Medema JP. Cancer stem cells--important players in tumor therapy
resistance. FEBS J. 2014;281:4779–91.
55. Frączek N, Bronisz I, Pietryka M, Kępińska D, Strzała P, Mielnicka K, et al.
An outline of main factors of drug resistance influencing cancer therapy.
J Chemother. 2016;28:457–64.
56. Zheng HC. The molecular mechanisms of chemoresistance in cancers.
Oncotarget. 2017;8:59950–64.
57. Herr MJ, Kotha J, Hagedorn N, Smith B, Jennings LK. Tetraspanin CD9
promotes the invasive phenotype of human fibrosarcoma cells via
upregulation of matrix metalloproteinase-9. PLoS One. 2013;8:e67766.
58. Li PY, Lv J, Qi WW, Zhao SF, Sun LB, Liu N, et al. Tspan9 inhibits the
proliferation, migration and invasion of human gastric cancer SGC7901 cells
via the ERK1/2 pathway. Oncol Rep. 2016;36:448–54.
59. Ranjan A, Bane SM, Kalraiya RD. Glycosylation of the laminin receptor (α3β1)
regulates its association with tetraspanin CD151: Impact on cell spreading,
motility, degradation and invasion of basement membrane by tumor cells.
Exp Cell Res. 2014;322:249–64.
60. Schröder HM, Hoffmann SC, Hecker M, Korff T, Ludwig T. The tetraspanin
network modulates MT1-MMP cell surface trafficking. Int J Biochem Cell Biol.
2013;45:1133–44.
61. Gu H, Chen C, Hao X, Wang C, Zhang X, Li Z, et al. Sorting protein VPS33B
regulates exosomal autocrine signaling to mediate hematopoiesis and
leukemogenesis. J Clin Invest. 2016;126:4537–53.
62. Bohlius J, Tonia T, Nüesch E, Jüni P, Fey MF, Egger M, et al. Effects of
erythropoiesis-stimulating agents on fatigue- and anaemia-related
symptoms in cancer patients: systematic review and meta-analyses of
published and unpublished data. Br J Cancer. 2014;111:33–45.
63. Liang R, Ghaffari S. Mitochondria and FOXO3 in stem cell homeostasis,
a window into hematopoietic stem cell fate determination. J Bioenerg
Biomembr. 2017;49:343–6.
64. Yukawa H, Suzuki K, Aoki K, Arimoto T, Yasui T, Kaji N, et al. Imaging of
angiogenesis of human umbilical vein endothelial cells by uptake of
exosomes secreted from hepatocellular carcinoma cells. Sci Rep. 2018;8:6765.
65. Greening DW, Gopal SK, Mathias RA, Liu L, Sheng J, Zhu HJ, et al.
Emerging roles of exosomes during epithelial-mesenchymal transition
and cancer progression. Semin Cell Dev Biol. 2015;40:60–71.
66. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular
facilitators. FASEB J. 1997;11:428–42.
67. Charrin S, le Naour F, Silvie O, Milhiet PE, Boucheix C, Rubinstein E.
Lateral organization of membrane proteins: tetraspanins spin their web.
Biochem J. 2009;420:133–54.
68. Bailey RL, Herbert JM, Khan K, Heath VL, Bicknell R, Tomlinson MG.
The emerging role of tetraspanin microdomains on endothelial cells.
Biochem Soc Trans. 2011;39:1667–73.
69. Wang HX, Li Q, Sharma C, Knoblich K, Hemler ME. Tetraspanin protein
contributions to cancer. Biochem Soc Trans. 2011;39:547–52.
70. Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M,
et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of
exosome-induced endothelial cell activation. Cancer Res. 2010;70:1668–78.
71. Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al.
Proteomic comparison defines novel markers to characterize heterogeneous
populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A.
2016;113:E968–77.
72. Rana S, Claas C, Kretz CC, Nazarenko I, Zoeller M. Activation-induced
internalization differs for the tetraspanins CD9 and Tspan8: Impact on tumor
cell motility. Int J Biochem Cell Biol. 2011;43:106–19.
73. Sachs N, Secades P, van Hulst L, Song JY, Sonnenberg A. Reduced
susceptibility to two-stage skin carcinogenesis in mice with epidermis-
specific deletion of CD151. J Invest Dermatol. 2014;134:221–8.
74. Klosek SK, Nakashiro K, Hara S, Shintani S, Hasegawa H, Hamakawa H.
CD151 forms a functional complex with c-Met in human salivary gland
cancer cells. Biochem Biophys Res Commun. 2005;336:408–16.
75. Kariya Y, Kariya Y, Gu J. Roles of laminin-332 and alpha6beta4 integrin in
tumor progression. Mini Rev Med Chem. 2009;9:1284–91.
76. Novitskaya V, Romanska H, Dawoud M, Jones JL, Berditchevski F.
Tetraspanin CD151 regulates growth of mammary epithelial cells in three-
dimensional extracellular matrix: implication for mammary ductal carcinoma
in situ. Cancer Res. 2010;70:4698–708.
77. Romanska HM, Berditchevski F. Tetraspanins in human epithelial
malignancies. J Pathol. 2011;223:4–14.
78. Ramovs V, Te Molder L, Sonnenberg A. The opposing roles of laminin-
binding integrins in cancer. Matrix Biol. 2017;57-58:213–43.
79. Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in
cancer progression. Biochim Biophys Acta. 2013;1833:3481–98.
80. Benvenuti S, Comoglio PM. The MET receptor tyrosine kinase in invasion
and metastasis. J Cell Physiol. 2007;213:316–25.
81. Brabletz T. To differentiate or not--routes towards metastasis. Nat Rev Cancer.
2012;12:425–36.
82. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-
mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.
83. Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-
mesenchymal transition. Sci Signal. 2014;7:re8.
84. Gawlik-Rzemieniewska N, Bednarek I. The role of NANOG transcriptional
factor in the development of malignant phenotype of cancer cells.
Cancer Biol Ther. 2016;17:1–10.
85. Stipp CS. Laminin-binding integrins and their tetraspanin partners as
potential antimetastatic targets. Expert Rev Mol Med. 2010;12:e3.
86. Wang Z, von Au A, Schnölzer M, Hackert T, Zöller M. CD44v6-competent tumor
exosomes promote motility, invasion and cancer-initiating cell marker expression
in pancreatic and colorectal cancer cells. Oncotarget. 2016;7:55409–36.
87. Yang XH, Mirchev R, Deng X, Yacono P, Yang HL, Golan DE, et al. CD151
restricts the α6 integrin diffusion mode. J Cell Sci. 2012;125(Pt 6):1478–87.
88. Longo N, Yáñez-Mó M, Mittelbrunn M, de la Rosa G, Muñoz ML, Sánchez-
Madrid F, et al. Regulatory role of tetraspanin CD9 in tumor-endothelial cell
interaction during transendothelial invasion of melanoma cells. Blood.
2001;98:3717–26.
89. Lin Q, Peng S, Yang Y. Inhibition of CD9 expression reduces the metastatic
capacity of human hepatocellular carcinoma cell line MHCC97-H. Int J Oncol.
2018;53:266–74.
90. Gilsanz A, Sánchez-Martín L, Gutiérrez-López MD, Ovalle S, Machado-Pineda Y,
Reyes R, et al. ALCAM/CD166 adhesive function is regulated by the tetraspanin
CD9. Cell Mol Life Sci. 2013;70:475–93.
91. Gutiérrez-López MD, Gilsanz A, Yáñez-Mó M, Ovalle S, Lafuente EM,
Domínguez C, et al. The sheddase activity of ADAM17/TACE is regulated by
the tetraspanin CD9. Cell Mol Life Sci. 2011;68:3275–92.
92. Cook GA, Longhurst CM, Grgurevich S, Cholera S, Crossno JT Jr, Jennings LK.
Identification of CD9 extracellular domains important in regulation of CHO
cell adhesion to fibronectin and fibronectin pericellular matrix assembly.
Blood. 2002;100:4502–11.
93. Teicher BA. Targets in small cell lung cancer. Biochem Pharmacol.
2014;87:211–9.
94. Tang QH, Liu ZY, Zuo HJ, Liu ZX. Involvement of activation of C-met
signaling pathway in CD151-induced HUVECs angiogenesis. J Huazhong
Univ Sci Technolog Med Sci. 2015;35:35–41.
95. Cortese K, Sahores M, Madsen CD, Tacchetti C, Blasi F. Clathrin and LRP-1-
independent constitutive endocytosis and recycling of uPAR. PLoS One.
2008;3:e3730.
96. Herkenne S, Paques C, Nivelles O, Lion M, Bajou K, Pollenus T, et al.
The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.
Sci Signal. 2015;8:ra117.
97. Rao Malla R, Gopinath S, Alapati K, Gorantla B, Gondi CS, Rao JS. Knockdown
of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell
adhesion and invasion in glioma. Mol Carcinog. 2013;52:777–90.
98. Heiler S, Mu W, Zöller M, Thuma F. The importance of claudin-7
palmitoylation on membrane subdomain localization and metastasis-
promoting activities. Cell Commun Signal. 2015;13:29.
99. Xu D, Sharma C, Hemler ME. Tetraspanin12 regulates ADAM10-dependent
cleavage of amyloid precursor protein. FASEB J. 2009;23:3674–81.
100. Rose-John S. ADAM17, shedding, TACE as therapeutic targets.
Pharmacol Res. 2013;71:19–22.
101. Turunen SP, Tatti-Bugaeva O, Lehti K. Membrane-type matrix
metalloproteases as diverse effectors of cancer progression. Biochim
Biophys Acta. 2017;1864(11 Pt A):1974–88.
Zhao et al. Journal of Experimental & Clinical Cancer Research          (2018) 37:312 Page 22 of 23
102. Zhou P, Erfani S, Liu Z, Jia C, Chen Y, Xu B, et al. CD151-α3β1 integrin
complexes are prognostic markers of glioblastoma and cooperate with
EGFR to drive tumor cell motility and invasion. Oncotarget. 2015;6:
29675–93.
103. Sceneay J, Smyth MJ, Möller A. The pre-metastatic niche: finding common
ground. Cancer Metastasis Rev. 2013;32:449–64.
104. Kosaka N, Yoshioka Y, Tominaga N, Hagiwara K, Katsuda T, Ochiya T.
Dark side of the exosome: the role of the exosome in cancer metastasis and
targeting the exosome as a strategy for cancer therapy. Future Oncol. 2014;
10:671–81.
105. Wang J, De Veirman K, De Beule N, Maes K, De Bruyne E, Van Valckenborgh
E, et al. The bone marrow microenvironment enhances multiple myeloma
progression by exosome-mediated activation of myeloid-derived suppressor
cells. Oncotarget. 2015;6:43992–4004.
106. Ng YH, Rome S, Jalabert A, Forterre A, Singh H, Hincks CL, et al. Endometrial
exosomes/microvesicles in the uterine microenvironment: a new paradigm
for embryo-endometrial cross talk at implantation. PLoS One. 2013;8:e58502.
107. Desterke C, Martinaud C, Guerton B, Pieri L, Bogani C, Clay D, et al.
Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal
interactions in primary myelofibrosis. Haematologica. 2015;100:757–67.
108. Clay D, Rubinstein E, Mishal Z, Anjo A, Prenant M, Jasmin C, et al. CD9 and
megakaryocyte differentiation. Blood. 2001;97:1982–9.
109. Oritani K, Wu X, Medina K, Hudson J, Miyake K, Gimble JM, et al. Antibody
ligation of CD9 modifies production of myeloid cells in long-term cultures.
Blood. 1996;87:2252–61.
110. Spring FA, Griffiths RE, Mankelow TJ, Agnew C, Parsons SF, Chasis JA, et al.
Tetraspanins CD81 and CD82 facilitate α4β1-mediated adhesion of human
erythroblasts to vascular cell adhesion molecule-1. PLoS One. 2013;8:e62654.
111. Han P, Guo X, Story C. Role of beta(1)-integrins and their associated
tetraspanin molecules in fibronectin-enhanced megakaryopoiesis.
Cytotherapy. 2004;6:465–75.
112. Menon V, Ghaffari S. Transcription factors FOXO in the regulation of
homeostatic hematopoiesis. Curr Opin Hematol. 2018;25:290–8.
113. Azab AK, Quang P, Azab F, Pitsillides C, Thompson B, Chonghaile T, et al.
P-selectin glycoprotein ligand regulates the interaction of multiple
myeloma cells with the bone marrow microenvironment. Blood.
2012;119:1468–78.
114. Krause DS, Lazarides K, Lewis JB, von Andrian UH, Van Etten RA. Selectins
and their ligands are required for homing and engraftment of BCR-ABL1+
leukemic stem cells in the bone marrow niche. Blood. 2014;123:1361–71.
115. Gros SJ, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Effenberger K,
et al. Involvement of CXCR4 chemokine receptor in metastastic HER2-
positive esophageal cancer. PLoS One. 2012;7:e47287.
116. Mühlethaler-Mottet A, Liberman J, Ascenção K, Flahaut M, Balmas-Bourloud
K, Yan P, et al. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary
but Complex Control of Neuroblastoma Metastatic Cell Homing. PLoS One.
2015;10:e0125616.
117. Arnaud MP, Vallée A, Robert G, Bonneau J, Leroy C, Varin-Blank N, et al. CD9,
a key actor in the dissemination of lymphoblastic leukemia, modulating
CXCR4-mediated migration via RAC1 signaling. Blood. 2015;126:1802–12.
118. Yoshida T, Kawano Y, Sato K, Ando Y, Aoki J, Miura Y, et al. A CD63 mutant
inhibits T-cell tropic human immunodeficiency virus type 1 entry by
disrupting CXCR4 trafficking to the plasma membrane. Traffic.
2008;9:540–58.
119. Head BP, Patel HH, Insel PA. Interaction of membrane/lipid rafts with the
cytoskeleton: impact on signaling and function: membrane/lipid rafts,
mediators of cytoskeletal arrangement and cell signaling. Biochim Biophys
Acta. 2013;1838:532–45.
120. Guidolin D, Marcoli M, Tortorella C, Maura G, Agnati LF. G protein-coupled
receptor-receptor interactions give integrative dynamics to intercellular
communication. Rev Neurosci. 2018. https://doi.org/10.1515/revneuro-2017-0087.
121. Verweij FJ, Bebelman MP, Jimenez CR, Garcia-Vallejo JJ, Janssen H, Neefjes J,
et al. Quantifying exosome secretion from single cells reveals a modulatory
role for GPCR signaling. J Cell Biol. 2018;217:1129–42.
122. Ramchandani D, Weber GF. Interactions between osteopontin and vascular
endothelial growth factor: Implications for cancer. Biochim Biophys Acta.
2015;1855:202–22.
123. Shibuya M. Vascular endothelial growth factor and its receptor system:
physiological functions in angiogenesis and pathological roles in various
diseases. J Biochem. 2013;153:13–9.
124. Cheng N, Brantley DM, Chen J. The ephrins and Eph receptors in
angiogenesis. Cytokine Growth Factor Rev. 2002;13:75–85.
125. Barreiro O, Zamai M, Yáñez-Mó M, Tejera E, López-Romero P, Monk PN, et al.
Endothelial adhesion receptors are recruited to adherent leukocytes by
inclusion in preformed tetraspanin nanoplatforms. J Cell Biol. 2008;183:527–42.
126. Wadkin JCR, Patten DA, Kamarajah SK, Shepherd EL, Novitskaya V,
Berditchevski F, et al. CD151 supports VCAM-1-mediated lymphocyte
adhesion to liver endothelium and is upregulated in chronic liver disease
and hepatocellular carcinoma. Am J Physiol Gastrointest Liver Physiol.
2017;313:G138–49.
127. Nomura S, Iwata S, Hatano R, Komiya E, Dang NH, Iwao N, et al. Inhibition of
VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9
through regulation of lipid raft microdomains. Biochem Biophys Res
Commun. 2016;474:111–7.
128. Tugues S, Honjo S, König C, Padhan N, Kroon J, Gualandi L, et al.
Tetraspanin CD63 promotes vascular endothelial growth factor receptor
2-β1 integrin complex formation, thereby regulating activation and
downstream signaling in endothelial cells in vitro and in vivo. J Biol Chem.
2013;288:19060–71.
129. Klein-Soyer C, Azorsa DO, Cazenave JP, Lanza F. CD9 participates in endothelial
cell migration during in vitro wound repair. Arterioscler Thromb Vasc Biol.
2000;20:360–9.
130. Colin S, Guilmain W, Creoff E, Schneider C, Steverlynck C, Bongaerts M, et al.
A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in
vivo tumour-induced angiogenesis and tumour growth. Br J Cancer. 2011;
105:1002–11.
131. Peng D, Zuo H, Liu Z, Qin J, Zhou Y, Li P, et al. The tetraspanin CD151-
ARSA mutant inhibits angiogenesis via the YRSL sequence. Mol Med Rep.
2013;7:836–42.
132. Peddibhotla SS, Brinkmann BF, Kummer D, Tuncay H, Nakayama M, Adams RH,
et al. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to
mediate basic fibroblast growth factor-specific angiogenic signaling.
Mol Biol Cell. 2013;24:933–44.
133. Takeda Y, Kazarov AR, Butterfield CE, Hopkins BD, Benjamin LE, Kaipainen A,
et al. Deletion of tetraspanin Cd151 results in decreased pathologic
angiogenesis in vivo and in vitro. Blood. 2007;109:1524–32.
134. Wang J, Huang Y, Zhang J, Wei Y, Mahoud S, Bakheet AM, et al.
Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor
lymphangiogenesis and lymphatic metastasis. Clin Chim Acta. 2016;461:
165–71.
135. Touat M, Ileana E, Postel-Vinay S, André F, Soria JC. Targeting FGFR
Signaling in Cancer. Clin Cancer Res. 2015;21:2684–94.
136. Chen PH, Bendris N, Hsiao YJ, Reis CR, Mettlen M, Chen HY, et al. Crosstalk
between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and
Epidermal Growth Factor Receptor Signaling Increases Metastasis. Dev Cell.
2017;40:278–88.
137. Delos-Santos RC, Garay C, Antonescu CN. Charming neighborhoods on the
cell surface: plasma membrane microdomains regulate receptor tyrosine
kinase signaling. Cell Signal. 2015;27:1963–76.
138. Pitulescu ME, Adams RH. Regulation of signaling interactions and receptor
endocytosis in growing blood vessels. Cell Adhes Migr. 2014;8:366–77.
139. Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and
beyond. Curr Opin Cell Biol. 2012;24:188–93.
140. Zhu YZ, Qian XJ, Zhao P, Qi ZT. How hepatitis C virus invades hepatocytes:
the mystery of viral entry. World J Gastroenterol. 2014;20:3457–67.
141. Vences-Catalán F, Levy S. Immune Targeting of Tetraspanins Involved in Cell
Invasion and Metastasis. Front Immunol. 2018;9:1277.
142. Thuma F, Zöller M. Outsmart tumor exosomes to steal the cancer initiating
cell its niche. Semin Cancer Biol. 2014;28:39–50.
Zhao et al. Journal of Experimental & Clinical Cancer Research          (2018) 37:312 Page 23 of 23
